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Ui3M-
" this I know, moreover, that to the human body it makes a great difference whether the 
bread be fine or coarse: with or without the hull, whether mixed with much or little water, 
strongly wrought or scarcely at all, baked or raw....whoever pays no attention to these 
things, or paying attention, does not comprehend them, how can he understand the diseases 
which befall man? For, by every one of these things, man is affected and changed this way, or 
that, and the whole of his life is subjected to them, whether in health, convalescence, or 
disease. Nothing else, then, can be more important or more necessary to know than these 
things."
(Hippocrates II)
SUMMARY
There is conflicting evidence as to the role of riboflavin in cancer. Riboflavin deficiency has 
been demonstrated to be both a protective factor and potentiating factor in experimental 
carcinogenesis. In human studies, riboflavin deficiency has been linked to oesophageal 
cancer, although there is little in the literature regarding the effects of riboflavin deficiency on 
the oral mucosa. This thesis examines the effects of riboflavin deficiency on the oral 
epithelium Chapter 1 is a review of riboflavin, its sources, functions, metabolism and 
measurement and the effects of riboflavin deficiency, particularly its role in cancer.
It was decided to attempt to induce riboflavin deficiency in the hamster. This animal was 
chosen with a view to using the frequently used hamster cheek pouch model of experimental 
oral carcinogenesis in subsequent studies. Chapter 2 describes the method of bleeding of the 
hamsters and verification that testing of riboflavin levels was possible on the small sample 
size available. Optimisation of the erythrocyte glutathione reductase test for hamster blood is 
described. The biochemical criteria for assessing the presence of riboflavin deficiency in the 
hamster were determined.
Chapter 3 describes the induction of riboflavin deficiency in a group of hamsters together 
with biochemical monitoring of their riboflavin status. Compartment and cell analysis of the 
lingual epithelium was undertaken. A number of difficulties were encountered in the 
experiment. Firstly, both experimental and control hamsters suffered from gastro-enteritis 
(wet tail) and several subsequently died, reducing the numbers available for analysis. Analysis
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of the riboflavin content of the diet indicated that the difference between the experimental 
and control diets was less than expected.
In Chapter 4 the problems which were met and possible avenues for future research are 
discussed.
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CHAPTER 1
RIBOFLAVIN IN MEDICINE-INTRODUCTION AND REVIEW OF THE 
LITERATURE
1.1 HISTORICAL INTRODUCTION
The existence of riboflavin (vitamin B2) was first realised in 1917 when Emmett and McKim 
showed there was a dietary growth factor for rats in rice polishings. Shortly after thiamine 
was isolated from yeast concentrates, Emmett and Luros (1920) suggested the presence of a 
second nutritional factor which unlike thiamine, was a thermostable growth promoting 
substance. The complexity of this factor was not initially realised, due to the fact that animal 
assays were used to determine the factors and not all animal species responded similarly. 
However, once this was realised, the thermostable "factor" was designated "vitamin B2 
complex" and was found to consist of riboflavin (a rat, growth-promoting factor), pyridoxal 
(a rat, pellagra-preventing factor), pantothenic add (a chick, antidermatitis factor), and 
nicotinic add (a human, pellagra-preventing factor).
Whilst in 1927 the British Medical Research Council proposed the name vitamin B2 for this 
heat stable component, in the USA it was known as vitamin G. Attempts to isolate it began 
in 1932. Within one year, crystals of "oroflavin" were isolated from egg white by T. 
Wagner-Jauregg at R  Kuhn's Institute. Previous investigators had succeeded in obtaining 
impure preparations of flavin which were given a variety of names such as lactochrom, 
cytoflav and ilyochrome, but it was not until 1932 that this substance was recognised as a 
vitamin.
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Warburg and Christian in 1932 isolated a yellow enzyme which contained riboflavin and 
which helped in the understanding of riboflavin biochemistry. In 1933, Gyorgy et al isolated 
pure vitamin B2 from milk and recognised its growth promoting activity. By 1935 Kuhn et al 
and Karrer et al. had confirmed the structure and achieved the synthesis of riboflavin. By this 
stage there was some confusion due to the variety of names and reported symptoms arising 
from deficiency ofvitamin B2 (Guha, 1935). The Council on Pharmacy and Chemistry (1937) 
agreed on its nomenclature and the name flavin, was given to the water-soluble pigment 
necessary for the normal nutrition of the rat and for growing chicks. The Conference of the 
American Chemical Society decided to use the name flavin, not lactoflavin as it was not 
initially isolated from milk, but from egg white. The name riboflavin was eventually decided 
upon, as it is a ribose derivative of isoalloxazine. It is also referred to as vitamin B2 as it was 
the first member of the "vitamin B2 complex1' to be isolated.
1.2 RIBOFLAVIN IN NATURE
1.2.1 Isolation and Structure
Riboflavin is a fine, orange-yellow crystalline powder which is practically odourless, but 
which has a bitter taste (Street and Street, 1952). Water solutions give a greenish, yellow 
fluorescence (Cooperman and Lopez, 1984). Riboflavin is found in nature in three forms; as 
free riboflavin, riboflavin 51 phosphate (FMN) and flavin adenine dinucleotide (FAD), the 
latter two of which are protein bound. Most of the riboflavin found in nature is protein 
bound. Some of the proteins involved have been identified as albumin and immunoglobulins 
(Merrill et a l, 1979 and 1981). One particular binding protein of the immunoglobulin group 
appears to correlate with pregnancy. Binding to plasma proteins facilitates the delivery of
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riboflavin to tissues or sequesters it from glomerular filtration. The different types of flavins 
belong to the group known as the isoalloxazines, but can also be designated as 
benzopteridines. Riboflavin itself has the formula 7,8-dimethyl- lO-(lVD-ribityl) isoalloxazine 
(McCormick, 1990). Flavoproteins are ubiquitous, being present in all biological fluids and 
tissues. FAD has a greater molecular weight than FMN or riboflavin itself Riboflavin itself 
has various melting points due to the polymorphism of the crystals.
1.2.2 Functions of Riboflavin
FMN and FAD are found in a large number of systems which function in carbohydrate, fat 
and lipid metabolism (Cooperman and Lopez, 1984). They serve as agents for the transfer of 
hydrogen between the nicotinic acid-containing coenzymes I and II and the iron-porphyrin 
cytochromes. Riboflavin participates in enzymatic reactions through intermediate free radical 
forms. It is essential for growth and repair in species from protozoa to man. It is important in 
both the preventive and radical quenching antioxidant defence systems of the tissues and the 
immune system by being involved in the regeneration of reduced glutathione (Bates and 
Thumham, 1991). There appears to be a lower limit of hepatic flavin levels compatible with 
life (Fass and Rivlin, 1969). Riboflavin is also necessary for the conversion of pyridoxine and 
folic add into their coenzyme forms (Cooperman and Lopez, 1984).
1.2.3 Biosynthesis of Riboflavin
Many micro-organisms and plants synthesise riboflavin from simple precursors, such as 
purine (guanine). This serves as an obligatory precursor with clearance of the imidazole 
portions of the purine with loss of carbon at position 8, before incorporation of 
diaminopyrimidine. Unusually large quantities of riboflavin are produced by some spedes of
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micro-organisms such as Candida species. Commercially available riboflavin is made by 
bacterial synthesis.
1.3 RIBOFLAVIN IN THE BODY
1.3.1 Sources
Riboflavin is present to some degree in virtually all naturally occurring foodstuffs. Liver and 
cooked beef have very high levels and cholorophyll-containing plants such as broccoli, 
asparagus and other green vegetables also contain a considerable amount. Most riboflavin 
consumed in Europe is derived from milk, meat, fish and eggs, whereas in developing 
countries it is principally supplied by cereals or starchy roots, although cereals are a poor 
source of riboflavin. The riboflavin content of foods can be affected by handling, processing 
and storing. For example milk loses hardly any of its riboflavin when it is pasteurised but 
loses 71 percent, after four hours in direct sunlight. This sensitivity to light is important if 
foods are sun-dried (Hunt, 1975). Faecal bacterial flora are a major vitamin source for 
coprophagic rodents (Hill, 1997).
1.3.2 Absorption
There appears to be considerable variation in the absorption of riboflavin among different 
species. In man it has been studied by following the urinary excretion. Riboflavin appears to 
be rapidly absorbed as shown by the early appearance of peak excretion rates and the parallel 
decline of the oral and intravenous curves if the vitamin is given orally. It is probable that 
absorption is limited to the proximal small intestine.
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From experimentation, there appears to be a capacity-limited transport process (Jusko and 
Levy, 1975). FMN is hydrolysed in the upper gastrointestinal tract, giving free riboflavin 
which enters the mucosal cells of the small intestine. It is then phosphorylated to FMN by 
flavokinase. FMN enters the portal system bound to albumin and travels to the liver where it 
is converted to FAD. In experiments where bilateral nephrectomy was carried out and 
intravenous riboflavin was administered, it was rapidly excreted into the small intestine, 
especially the duodenum (Selye, 1943).
In animals the absorption of riboflavin appears to be different from man. Early experiments 
appeared to show that in rats and hamsters, absorption occurs by passive diffusion. This was 
confirmed by other workers in rats but little information exists on the situation in the hamster 
(Jusko and Levy, 1975). In the rat, the little absorption that does occur, takes place in the 
ileum and so this is a poor model for extrapolation to man.
1.3.3 Metabolism in Man
The body tends to facilitate the maintenance of nutritionally adequate levels of vitamin B2 as 
well as the rapid elimination of excessive loads. If large doses are given, the easily saturated 
specialised transport process of the small intestine limits absorption whereas if only small 
doses are given, absorption is rapid and efficient. If there are high circulating levels there is 
rapid elimination in urine or bile. Also, if the body levels are high, little is bound to plasma or 
present as FMN or FAD, whereas if the body levels are low, most riboflavin is protein bound 
and little is excreted in the urine. An excess of riboflavin leads to only a slight increase in the 
storage of riboflavin in the liver. Most of the flavin taken in is stored as coenzymes which 
function catalytically with specific proteins.
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1.3.4 Excretion
Riboflavin is phosphorylated to FMN in the intestine and to FAD in the liver. Elimination 
then occurs primarily by renal excretion, but also by biliary excretion and minor losses with 
body secretions and metabolic interconversions. Renal excretion in man involves glomerular 
filtration, tubular secretion and tubular reabsorption. If a large parenteral dose of riboflavin is 
given, man excretes most of this in the urine (Axelrod et al., 1941). Typical excretion of 
riboflavin in the urine of an adult is 200pg in a 24 hour period. This decreases to 40-70pg in 
deficiency states. Dessner (1952) aimed to find a clinically useful method for the standard 
determination of riboflavin in man. He measured the amount of riboflavin excreted in the 
urine, using the fluorometric method, following a 5mg dose of riboflavin given 
intramuscularly. He proposed that if more than 30 percent of the 5mg dose was excreted, 
there was no deficiency whereas less than 20 percent excretion meant there was a decided 
deficiency. The Interdepartmental Committee on Nutrition for National Defence (ICNND) 
lists excretions of less than 27pg riboflavin/gm creatinine as an indicator of deficiency in man 
(Cooperman and Lopez, 1984).
1.3.5 Requirements
It is difficult to assess what is the correct daily requirement for riboflavin as it is unlikely that 
clinical signs and symptoms are the most sensitive index of adequate status (Bates and 
Thumham, 1991). In humans the daily requirement of riboflavin varies from 0.4mg/day in 
young children to 1.3-1.7mg/day in adults (Cooperman and Lopez, 1984). The optimum 
level is obviously that which promotes the highest level of health. However, nutritional 
requirements may differ according to sex, age, activity or physiological state and can be 
influenced by drugs, smoking, alcohol and other factors (Sauberlich, 1984). It has been
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suggested that the recommended daily allowance in some parts of the world is too high and 
requires revision (Bran et a l, 1990). Antibiotics such as penicillin or tetracycline can reduce 
the requirements for riboflavin in several species by inhibiting microorganisms in the gut that 
compete for riboflavin (Cooperman and Lopez, 1984).
1.4 MEASUREMENT OF RIBOFLAVIN IN THE BODY
The status of riboflavin in man has been assessed in a great variety of ways. Microbiological, 
fluorometric and enzymatic testing have been carried out, the latter now being the most 
popular although "high performance" liquid chromatography (HPLC) has been used more 
recently. Assays can be used to measure riboflavin in the urine, plasma, serum, erythrocytes 
or whole blood. One of the main problems with many of the methods is that the results 
reflect recent dietary intake rather than body or functional stores.
1.4.1 Microbiological Method
This method can be used to measure riboflavin levels in blood, urine and tissue samples. This 
method is based on the fact that many lactic acid producing organisms require exogenous 
riboflavin. Tetrahymena pyriformis (a protozoan dliate), Lactobacillus casei and 
Leuconostoc mesenteroides have been used. If blood is to be tested, it is first citrated and 
frozen. FMN and FAD are deproteinized into their free forms and the supernatant obtained 
by centrifugation. The supernatant is added to a number of flasks containing basal medium 
and various quantities of distilled water. Various dilutions of serum are therefore produced. 
The flasks are inoculated with culture and incubated for three days. Growth is measured in 
optical density units. The measurements are plotted on a graph and values for riboflavin
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calculated from standard curves. The method using Lactobacillus is virtually the same as 
previously described, but as an alternative to measuring the turbidity, the acidity can be 
measured (Baker and Frank, 1975).
The microbiological method is simple and the required equipment is inexpensive. However, if 
the subjects have received antimetabolites eg antibiotics, these may interfere with the growth 
of the micro-organisms. Strong et al. (1941) studied the applicability of the bacterial method 
in assessing the amount of riboflavin in the blood and urine of humans and animals and the 
effect of varied intake on urinary excretion. They felt that the direct assay of blood furnished 
a reliable measurement of riboflavin present.
Of the organisms described, Tetrahymena pyriformis responds equally well on a molar basis 
to riboflavin, FMN and FAD, whereas Lactobacillus casei uses FMN and FAD, but this is 
not proportional to the molar concentration of riboflavin in these analogues (Baker and 
Frank, 1975). Also, Lactobacillus casei responds to many other riboflavin analogues that 
may or may not have biological activity.
Unfortunately, although the microbiological method was thought to be more specific than the 
fluorometric method (see below), it requires larger quantities of tissues and is cumbersome to 
cany out (Bamji et al., 1973). It is not the method of choice in most UK hospital 
laboratories.
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1.4.2 Fluorometric Method
With this method the intensity of the natural fluorescence of flavins or the fluorescence of 
lumiflavins derived from flavins can be measured. Free riboflavin exists in only tiny quantities, 
therefore, total riboflavin in add extracts is a measure of that resulting from hydrolysis of 
FMN and FAD. Riboflavin and FMN have the same fluorescence whereas FAD is only 14 
percent as fluorescent. Riboflavin is more readily extracted by benzyl alcohol from aqueous 
solution than FMN or FAD, whereas FAD is completely hydrolysed to FMN in 5 percent 
trichloroacetic acid in 20 hours at 37°C. Therefore, by manipulating a sample the 
fluorescence due to each component can be measured and the total riboflavin calculated 
(Baker and Frank, 1975).
However, this method is slow and the calculations are laborious. It does have the advantage 
of delineating the various flavins. The problem with this assay is that there may be 
interference from other non-specific fluorescent substances. Bamji et al (1973) generally 
found little difference between the microbiological method and the fluorometric method as 
regards consistency of results. Guinea pigs did give a slightly higher result than either human 
or rat samples. They proposed that this was possibly due to the presence of aforementioned 
non specific fluorescent substances in guinea pig tissues.
1.4.3 Enzymatic Method
This method does not directly measure actual riboflavin levels in the body. The vitamin in its 
coenzyme form participates in a specific enzymatic reaction. By measuring the activity of an 
enzyme which requires FAD as a coenzyme, an indirect measurement of riboflavin is 
obtained. This type of method is used to measure a number of vitamins such as thiamine and
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pyridoxine. For riboflavin, erythrocyte glutathione reductase (EGR) activity is examined 
(Baker and Frank, 1975).
This enzyme catalyses the reduction of oxidised glutathione (GSSG).
EGR(FAD)
NADPH + Ef + GSSG -► NADP+ + 2GSH
Erythrocyte glutathione reductase requires as a coenzyme, FAD, a phosphorylated form of 
riboflavin. EGR activity is altered in vivo by dietary riboflavin, (NADPH-nicotinamide 
adenine dinucleotide; GSH- reduced glutathione).
When erythrocyte stores of riboflavin are optimal, if additional supplies of FAD are added in 
vitro, little or no enzyme activity should occur. However, if there is a suboptimal supply with 
insufficient FAD, addition of FAD to the blood cells could stimulate enzyme activity. Glatzle 
et al. (1970) looked at 190 healthy subjects. They found only five subjects had an activation 
coefficient >1.27 and 99 percent of the remaining 185 patients were in the range 0.85-1.2. It 
was therefore decided that activation coefficients of 1.2 or more would be considered as an 
indication of biochemical vitamin B2 deficiency. They also advised that the results should be 
used with care as there may be stimulation of EGR activity when the haemolysate grows old 
and the presence of impurities may have an inhibiting effect.
Glatzle et a l (1973) demonstrated that activation coefficients in blood appeared to reflect 
quite well the flavin pool in body tissues such as the liver, making this a suitable technique to 
evaluate riboflavin status. Sharada and Bamji (1972) suggested that the correct interpretation
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and practical usefulness of the EGR test depended on exact information regarding the 
influence of other nutrients. For example, although thiamine, folic add and vitamin C 
defidency had no effect on EGR activity and riboflavin concentration, pyridoxine deficiency 
in rats caused a decrease in EGR activity while also causing an increase in erythrocyte 
riboflavin concentration.
An ultramicro enzymatic method has been described and used in field studies in Thailand 
(Ihumham et al., 1970). It requires only a small volume of blood from a finger prick. Some 
workers suggest that BGR assay (whole blood glutathione reductase) offers analytical and 
technical advantages over EGR assays and that it is a reliable and practical method for 
assessing riboflavin status in man (Garry and Owen, 1976).
1.4.4 High Performance Liquid Chromatography
High performance liquid chromatography (HPLC) has been used more recently, as a method 
of assessing riboflavin and appears to be reliable, fast and reasonably accurate (Fidanza et 
al., 1989 & Johansen and Edhind, 1990). There appears to be a good correlation with the 
EGR method (Fidanza et al., 1989). A wide variety of structural analogues of FMN can be 
obtained in pure form by HPLC (Nielson et al., 1983). Venous blood samples are taken, 
centrifuged and following treatment with various reagents, added to a SPE-cohimn (solid 
phase extraction). There can be much error in the technique due to evaporation of organic 
solvents. Internal standards need to be used to minimise error and these should be of close 
structural similarity to riboflavin (Lambert et al., 1985). Botticher and Botticher (1987) 
described a method of determining vitamins Bi, B2 and B6 in serum and whole blood from 
only one sample preparation.
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1.5 RIBOFLAVIN DEFICIENCY
1.5.1 Riboflavin Deficiency in Humans
It was thought at one time that riboflavin deficiency was probably the most prevalent 
avitaminosis. However, deficiencies of the water soluble vitamins often occur together 
(Street and Street, 1952). It is unlikely that pure riboflavin deficiency occurs in nature as 
riboflavin is closely linked with deficiencies of the other B group vitamins. When 
experimental deficiency is produced in humans, oral abnormalities develop, such as lesions at 
the angles of the mouth and on the lips. Signs such as dermatitis of the nasolabial folds, 
vestibule of the nose, ears and eyelids and diminution of the ability to perceive flicker have 
been reported (Horwitt et al., 1949).
Where riboflavin deficiency is endemic there is soreness and burning of the lips, mouth and 
tongue. The lips are red, denuded, diy, chapped and fissured. There is angular stomatitis. The 
tongue is purple and pebbled. Photophobia and burning and itching of the eyes, visual fatigue 
and dimness of vision are present (Goldsmith, 1975).
Riboflavin deficiency has been reported as providing the host with resistance to malaria, and 
if riboflavin status is improved the host has increased susceptibility to malarial infection. 
However, this is more likely to be due to action on the parasite rather than increased defence 
by the host (Bates et al., 1986). Dutta et al. (1988) examined the effects of dietary riboflavin 
deficiency on the fragility of red blood cells, on the reticulocyte count and on the 
concentration of ATP and reduced glutathione (GSH) in red blood cells, all of which have 
been suggested as being involved in the protective mechanism. They demonstrated that the 
erythrocytes of deficient animals were more resistant to haemolysis by H20 2 and
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ferriproto-porphyria-IX, that GSH was actually increased and ATP and the reticulocyte 
count were unaltered. Thus it would appear that the protective mechanism is more likely to 
be due to direct effects on the parasite rather than the metabolic status of the host.
Biochemical evidence of riboflavin deficiency has been found to be more prevalent in oral 
contraceptive users (Newman et al., 1978). This does not necessarily mean there are signs 
and symptoms of deficiency (Sanpitak and Chayutimonkul, 1974). Iyengar (1973) analysed 
the diets of pregnant women of low income groups in India. Those suffering from angular 
stomatitis and glossitis were found to have a poor intake of riboflavin. When their diet was 
supplemented with riboflavin some improved, however there were also some who did not 
respond until they were also treated with pyridoxine. There have been reports of riboflavin 
deficiency in chronic diabetics. Reddi et al. (1990), in an experiment on streptozotocin 
diabetic rats, suggested that this may be related to augmented urinary excretion of riboflavin.
Biochemical similarities exist between hypothyroidism and riboflavin deficiency (Rivlin et al., 
1968). Two flavoprotein enzymes, in addition to FMN and FAD were depressed in both 
hypothyroidism and riboflavin deficiency. It was postulated that the reduction in activities of 
these enzymes was related to the common factor of diminished synthesis of FMN and FAD 
from riboflavin. Alcoholics are often riboflavin deficient, this probably being due to 
inadequate intake as they often have multiple vitamin deficiencies (Rosenthal et al., 1973). 
Copper, zinc, cobalt, manganese, iron and cadmium are thought to chelate with riboflavin 
and FMN and may induce deficiency (Cooperman and Lopez, 1984).
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1.5.2 F.vperimental Riboflavin Deficiency in Animals
Riboflavin deficiency can be induced experimentally by feeding a riboflavin deficient diet 
(Kim and Roe, 1985), administering a riboflavin antagonist, such as galactoflavin (Hoppel et 
al, 1979) or by chronic alcohol administration (Kim and Roe, 1985) The effects of riboflavin 
deficiency in a variety of species of animals have been widely documented. The majority of 
the work has been carried out in the rat model and this is reflected in the extensive literature 
available. There is little in the literature specifically describing the effects of riboflavin 
deficiency in the hamster.
Hamsters appear to require a higher dietary intake of riboflavin than either mice or rats. They 
need at least 6mg/kg diet as compared with l-3mg/kg in the mouse and 2.5mg/kg in the rat 
(Cooperman and Lopez, 1984). Indeed, the recommended levels usually vary between 12 
and 20mg/kg of diet (National Academy of Sciences, 1978). Methods of monitoring 
biochemically the progression of riboflavin deficiency vary, but in an experiment on hamsters 
reported by Kim and Roe (1985) the erythrocyte glutathione reductase test was utilised. 
They found that initially there was considerable fluctuation of erythrocyte ghiathione 
reductase activation coefficients. This occurred in both experimental and control animals. 
They proposed that this was likely to be due to refection, as previous experiments with rats 
fitted with tail cups had prevented coprophagy and allowed riboflavin deficiency to develop 
without early recovery. Salley and Weatherred, (1964) carried out studies to obtain basic 
information on riboflavin deficiency in Syrian hamsters. Forty two animals were divided into 
three groups; one fed a diet deficient in riboflavin ad lib, one pair-fed but supplemented with 
1.6mg riboflavin/lOOg of diet and lastly a group fed a diet with sufficient riboflavin ad lib. 
Two animals from each group were sacrificed at weekly intervals over seven weeks. Using
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the microbiological method of analysis they found liver riboflavin levels of near 40fig in the 
supplemented groups, but these fell to 15fig by the sixth week in the group fed a riboflavin 
deficient diet. Plasma levels showed no significant variations throughout the experimental 
period in any of the groups. Clinical signs of deficiency, such as weight loss, lethargy, matted 
fur and tremors were noted. These effects only became apparent when the liver riboflavin 
levels fell below 60 percent of the controls. They concluded that riboflavin content of liver 
provided a quantitative measure of the acute deficiency state before other signs became 
apparent. This, unfortunately is not a feasible method of monitoring riboflavin levels in 
experiments which require the animals to survive throughout the experimental period. It must 
also be noted that the numbers of animals in each group was small It is difficult to know 
whether the lack of an effect on the plasma was a reflection of the technique of testing or a 
true reflection that riboflavin levels are maintained in the plasma despite filling levels in other 
tissues.
The majority of early experiments which involved riboflavin deficiency in rats or mice, did 
not monitor riboflavin levels biochemically, throughout the experimental period, often relying 
on weight loss alone as an indicator of riboflavin status.
Experimental riboflavin deficiency has a number of profound effects on the tissues, especially 
epithelial Early in the history of riboflavin studies, Adams (1936) supplied white rats with a 
riboflavin deficient diet. They developed thinning of the hair and alopecia after 35 days. He 
concluded that there was a marked reduction in the rate of respiration of the skin cells. No 
testing of riboflavin levels was carried out. Reported signs in the rat model include, ragged 
fur, hair of uneven length, scaly skin, areas of alopecia due to separation of the basal portions
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of hair shafts from the anchoring cells and conjunctivitis with comeal vascularisation and 
opacity. Lippincott and Morris (1942) reported that young mice fed on a riboflavin deficient 
diet, had thin hair about the snout and ears and that they developed cracks and fissures on 
their snouts and the inner surfaces of their front legs. Histologically there was focal atrophy 
of the epidermis sometimes with the layer of keratin directly on the collagen fibres of the 
corium Myelin was lost in some areas and some animals had cataracts. As these experiments 
were carried out so soon after the discovery and isolation of riboflavin, doubt must be cast on 
the validity of the findings. It is likely that the animals were suffering from multiple vitamin 
deficiencies, rather than pure riboflavin deficiency.
When baboons were fed a riboflavin deficient diet, they developed extensive scaling of the 
free, arms, hands and legs. Microscopically the cutaneous lesions demonstrated 
hyperkeratosis, acanthosis, extensive ''pseudocarcinomatous" hyperplasia with thickened, 
branching rete pegs, aberrant individual cell keratinisation and intraepidermal "epithelial 
pearl" formation. The oesophageal mucosa was thin and pale with penetrating ulcers and 
similar changes in the oral mucosa (Foy et al., 1972; Foy and Kondi, 1984). Not all the 
animals were on the riboflavin diet for the same amount of time (8-24 weeks) and in addition 
one of the animals was fed a riboflavin antagonist, galactoflavin. No subjective differences in 
histological findings were noted, but no quantitative histology was carried out. What was 
also of interest was the relative sparing of the ocular and respiratory epithelium, suggesting 
lower requirements for riboflavin of these tissues. Wynder and Klein (1965) fed mice a 
riboflavin deficient diet, varying in frt and carbohydrate content for up to nine weeks. 
Initially, there was atrophy of the squamous epithelium which paralleled the body weight and 
degree of deficiency, although again, no mention was made of riboflavin monitoring.
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Hyperkeratosis also occurred early on in the experimental period. Between the fifth and 
eighth weeks, a slightly irregular reduction of the epithelium of the tongue occurred, but in 
the seventh to ninth weeks epithelial hyperplasia occurred. Changes throughout the 
experimental period occurred more quickly in those animals fed a diet with higher fat 
content. Shaw and Phillips (1941) had previously found that symptoms of deficiency 
appeared earlier in rats on a high fat diet. No explanation was proposed for this.
As riboflavin deficiency progresses, the body weight reduces, although deficient rats have 
been found to consume 15-20 percent more calories to maintain the same weight as controls 
(Goldsmith, 1975). Young mice fed on a riboflavin deficient diet, failed to grow normally and 
died in 6-8 weeks while adult mice gradually lost weight and died in 8-10 weeks. The animals 
moved in a hunched position with a dragging or jerky gait (Lippincott and Morris, 1942). In 
one of the few experiments involving hamsters and riboflavin deficiency, Kim and Roe 
(1985) divided 36 hamsters into six groups, varying the riboflavin and alcohol content of 
liquid diets. They lost six animals during the experimental period of 13 weeks, although there 
was no explanation why and after the first two weeks of diet, the riboflavin restricted group 
gained less weight.
Norton et al. (1979) induced riboflavin deficiency in rats by administering galactoflavin, an 
antagonist of riboflavin, together with a riboflavin deficient diet. In the bone marrow, 
decreasing cellularity was noted as riboflavin deficiency progressed and by the fifth week, 
proeiythroblasts were noted to be absent. There appeared to be asynchrony of rat 
erythroblast maturation with a decrease in the rate of ribosome turnover. Demyelination of 
rat sciatic nerve fibres occurred, while nonmyelinated nerve fibres were unaffected. It has
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been suggested that the demyelination may be due to altered fatty acid metabolism (Norton 
etal., 1976).
Riboflavin deficient swine show retarded growth, with dermatitis, inco-ordination, nerve 
degeneration, comeal opacities and cataracts whereas riboflavin deficient dogs show ataxia, 
weight loss, weakness and fatty degeneration of the liver (Goldsmith, 1975).
1.5.3 Riboflavin Deficiency and Other Nutritional Deficiencies
It is unlikely that pure riboflavin deficiency is found in the general population. This is partly 
due to the feet that the foods which contain riboflavin also contain other nutrients and 
therefore if they were lacking in the diet, there would likely be multiple deficiencies. In 
addition, riboflavin is involved in the metabolism of other nutrients such as folic acid and 
pyridoxine. It is common to find deficiencies of several B group vitamins.
Vitamin B6 (pyridoxine) takes part in the transport of amino adds into and out of cells and 
red blood cells play an important role in the transport of amino acids (Anderson et a l , 1976). 
Krishnaswamy (1971) treated patients with oral lesions such as angular stomatitis and 
glossitis with riboflavin and vitamin B6. Seven out of 13 patients responded to riboflavin, 
although they required vitamin B6 for complete resolution of symptoms. Six required vitamin 
B6 with only a limited response to riboflavin. In those who had responded mainly to 
riboflavin, the transaminase activity was higher, with low activity in the group which 
primarily responded to vitamin B6. Riboflavin status appeared to modify the transaminase 
activity considerably. A group of patients with oral lesions and very low EGR activity were 
administered pyridoxine. There was a subsequent decrease in RBC riboflavin, but an increase
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in EGR activity and a good clinical response, suggesting that riboflavin is utilised in 
pyridoxine metabolism (Nutrition Reviews, 1972). The enzyme concerned with the 
conversion of pyridoxine to its active form pyridoxal phosphate is pyridoxine phosphate 
oxidase which is a FMN dependent enzyme (Nutrition Reviews, 1977). The utilisation of 
vitamin B6 depends on the conversion of the active compounds, pyridoxine in plants and 
pyridoxal and pyridoxamine in foods of animal origin, into pyridoxal phosphate (Nutrition 
Reviews, 1972). If rats are maintained on a vitamin B6 deficient diet, erythrocyte riboflavin 
increases. It may be that in the absence of pyridoxine, less riboflavin is utilised. A deficiency 
of riboflavin may also lead to a deficiency of pyridoxine. Conversion to the active form of 
vitamin B6 is increased if red cells are incubated with riboflavin. It may be that a significant 
proportion of ingested pyridoxine is metabolised by the red blood cells.
The similarities of changes in the neural tissues found between riboflavin deficient animals 
and humans with vitamin Bi2 deficiency stimulated Frenkel et al. (1979) to examine whether 
the tissue changes were caused by defective vitamin Bi2 function due to the requirement for 
riboflavin dependent oxidoreductase systems in Bi2 coenzyme synthesis and function. They 
failed to demonstrate abnormal enzyme reactions or an increase in odd chain fatty acids 
which is characteristically seen in Bi2 deficient states.
The effect of riboflavin on folic acid metabolism was examined by Dako and Hill (1980). 
They administered diets with varying amounts of folic add and riboflavin to groups of rats 
and then examined various parameters in the blood such as haemoglobin, red blood cells and 
the haematocrit. The highest values were in those receiving the full dosage of riboflavin and 
folic add. Folic acid alone gave lower values. However, if only a fifth of the full dosage of
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riboflavin was administered with the folic add, the haemoglobin values increased 
significantly. Bovina et a/. (1969) demonstrated the influence of riboflavin on the utilisation of 
folic acid for the biosynthesis of coenzyme derivatives, in particular in the reduction steps 
responsible for the conversion of folate to tetrafolate.
Riboflavin defidency appears to have some effect on the concentration of iron in the liver due 
to impaired absorption of dietary iron. Adelekan and Thumham (1986) demonstrated that 
there was a lower concentration of liver ferritin-Fe in riboflavin deficient rats with a 
significant increase in the erythrocyte glutathione reductase activation coefficients. They 
suggested that the reason iron absorption was impaired was due to the iron being retained 
more in the tissues, due to a decrease in the activity of the enzyme NADH-FMN 
oxidoreductase. This enzyme requires FMN which is reduced in riboflavin deficiency. Powers 
and Bates (1987) tried to determine whether riboflavin was required for iron metabolism. 
There was a significant increase in packed cell volume when riboflavin and iron were given 
together to patients suffering from defidendes. It was suggested that riboflavin may have a 
role in promoting iron utilisation in the erythroid marrow. Riboflavin defidency may impair 
the mobilisation of hepatic iron stores and possibly iron absorption.
A group of 37 patients with iron defidency anaemia was tested for pyridoxine status and for 
erythrocyte total riboflavin (Jacobs and Cavill, 1968a). In those patients with oral lesions 
there was a significant reduction in erythrocyte riboflavin levels, though the authors felt that 
this was of doubtful pathological significance.
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It would appear that there are a number of non specific oral manifestations such as glossitis 
and angular stomatitis that can be seen in conjunction with a number of nutritional 
deficiencies such as riboflavin, pyridoxine, folic acid, iron and vitamin Bi2. This can cause 
problems therefore in assigning any sign or symptom to a particular deficiency unless all are 
tested for.
1.5.4 Riboflavin Deficiency and Alcohol
Alcoholics are known to suffer from a variety of vitamin deficiencies. Such deficiencies in 
alcoholics may be due to low dietary intake, impaired absorption, deficient metabolic 
transformation due to hepatic hypofunction and impaired tissue storage. Majumdar et al. 
(1981) assessed the vitamin status of 12 chronic alcoholics and found six of the 12 were 
deficient in riboflavin. Normal levels of riboflavin were reached after treatment with 
intravenous vitamins. Rosenthal et al. (1973) found 11 out of 22 alcoholics admitted to 
hospital had riboflavin deficiency on testing although they did not exhibit any of the 
symptoms normally associated with such deficiency. Leevy et al. (1965) found significant 
reductions in the circulating levels of two or more B complex vitamins in more than 40 
percent of a group of malnourished alcoholics with liver disease. Although there were no 
signs of deficiency, electronmicroscopic examination of samples of liver from patients with 
riboflavin, folic add, pantothenic acid and pyridoxine defidency showed reversible 
enlargement of the mitochondria in the absence of pathological changes at the light 
microscope level
Stanko et al. (1978) tried to determine whether oral administration of naturally occurring 
chemical agents known to be hydrogen acceptors and/or necessary for efficient oxidative
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metabolism would protect the liver against the fat accumulating effect of ethanol Riboflavin 
was found to decrease the concentration of esterified fatty adds and if pyridoxine 
dihydroxyacetone was used, riboflavin potentiated its effect.
Kim and Roe (1985) studied the sequential development of riboflavin defidency in hamsters 
in response to alcohol administration and tried to determine whether it could be prevented by 
increasing the dietary intake of riboflavin. They found in a group of hamsters, that the most 
severely affected were the alcohol fed riboflavin depleted group while it appeared that 
supplementation with riboflavin prevented alcohol-induced riboflavin deficiency. It would 
appear that alcohol increases the requirement for riboflavin with specific effects on its 
absorption, metabolism and excretion.
As it is known that acute ethanol consumption and riboflavin deficiency each induces 
oxidative stress within tissues, Dutta et al. (1995) examined whether their combined effects 
would compromise the major antitoxidative system in the liver, reduced glutathione 
metabolism They found that while riboflavin deficiency alone did not compromise hepatic 
reduced glutathione (GSH) metabolism, ethanol consumption together with riboflavin 
deficiency depleted hepatic GSH, blunting enzyme activities and may therefore enhance 
alcohol induced liver injury.
1.6 RIBOFLAVIN AND CANCER
1.6.1 Introduction
It is estimated that greater than 90 percent of cancers are caused by environmental, dietary 
and lifestyle related factors and as 30 percent are due to tobacco and 40 percent dietary,
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about 70 percent could be prevented if people stopped smoking and modified their diets and 
lifestyles (Prasad, 1990). Exposure to one carcinogenic stimulus does not predestine the 
individual to develop a neoplasm, because familial, dietary, hormonal and gender related 
factors modulate the progression (Boyd and Reade, 1988; Cairns, 1981).
Calabrese (1979) challenged the role of the environment in carcinogenesis and felt that the 
figure of environmental factors initiating or promoting 85-90 percent of all cancers was 
misleading. He felt the critical role of the individual's health status as a modifying factor was 
neglected.
Many authors have attempted to correlate differences in food intake with the differences in 
incidence of various cancers in world populations. It is postulated that dietary factors play a 
vital role in the genesis of several major neoplasms especially gastric and colonic (Lowenfels 
and Anderson, 1977). However, it is difficult to assess the contribution of the diet generally 
to carcinogenesis due to the large number of chemicals with a wide and contradictory range 
of biological activities. Before recommendations are made to the public, the degree and 
certainty of risk has to be ascertained (Weinhouse, 1986).
Lyon et al. (1983) looked at the problems involved in epidemiological studies of diet and 
cancer. There appears to be a lack of understanding between nutritionists and 
epidemiologists, the nutritionists generally being more interested in current intake and 
nutritional status and epidemiologists more interested in food intake prior to the onset of 
cancer, which can be over a period of years.
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Elements of the diet may be initiators or complete carcinogens or may modulate 
carcinogenesis. It is difficult to measure the intake of individual food components if they have 
been consumed years earlier and so, much of the data is from laboratory studies. 
Unfortunately, due to the varying metabolic pathways in different species it is difficult to 
extrapolate results. Also, experimental diets usually compare extremes which are not usually 
applicable to humans, as variables are usually within a more modest range (Higginson and 
Sheridan, 1991).
Cancer has profound effects on nutritional status (Rivlin et al., 1983). Some tumours are 
supplied with amino acids at the expense of the host (Henderson and LePage, 1959). The 
relationship between vitamin metabolism and cancer is very complex, such as the effects of 
vitamins on the growth of the tumour, the effects of tumours on vitamin metabolism and the 
effects of vitamins on chemical carcinogens and antitumour chemotherapeutic agents 
(Nutrition Reviews, 1974). There appears to be a lot of contradictory evidence as to the 
relationship of riboflavin to cancer. Riboflavin deficiency has been implicated in both 
protection and causation of cancer. While riboflavin deficiency appears to prolong the 
survival of tumour-bearing animals it may also accelerate carcinogenesis (Rivlin, 1982).
1.6.2 Riboflavin Deficiency as a Protective Factor in Experimental Carcinogenesis 
Several authors have reported that riboflavin deficiency inhibits the number and rate of 
growth of some spontaneous and transplanted tumours. Riboflavin deficiency has been 
reported to reduce the size of previously developed lymphosarcoma transplants in mice 
(Stoerk and Emerson, 1949) and diminish the growth rate of Walker carcinoma in rats 
(Aposhian and Lambooy, 1951). There is reported to be non-specific inhibition of growth of
36
Walker rat carcinoma 256 in the presence of diethyl riboflavin, a potent antagonist of 
riboflavin (Kim et al., 1966). Rivlin et al (1973) tried to determine whether Novikoff 
hepatoma differs from normal tissue in its adaptation to riboflavin deficiency and whether the 
presence of the tumour alters the hepatic concentration of riboflavin, FMN and FAD. The 
survival of the rats in the deficient group was increased by 5.7-10.8 days. The concentration 
of FAD decreased to one third of its normal in the livers of deficient rats. FAD concentration 
in the hepatoma was one tenth that of the liver.
Riboflavin deficiency has also been reported to protect mice from the growth and spread of 
mammary tumours (Morris and Robertson, 1943). They did not monitor riboflavin levels, 
relying instead on weight loss. It is worth noting that the fit contents of the diets were not 
the same and as has been previously mentioned, the fit content can affect the rate of 
attainment of riboflavin deficiency (Shaw and Phillips, 1941). Morris (1947) aimed to 
determine the influence of vitamin intake on the in vivo growth of tumours already formed 
and in the genesis of cancer. He looked at the effects of rapid, extreme deficiency and partial 
depletion on the growth of spontaneous mammary tumours in mice. He found that rapid 
extreme deficiency of pantothenic acid and riboflavin decreased the rate of growth of 
spontaneous mammary adenocarcinomas. Deficiency of pyridoxine had no effect and if there 
was only partial depletion of pyridoxine, thiamine or riboflavin, there was no effect on the 
growth of the tumours. Riboflavin supplementation actually increased the number of 
tumours. Unfortunately, a number of the early experiments gave no information on whether 
the inhibition of growth rates was due to a reduction in number and/ or size of cells.
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Baker et al. (1981), found that tissue of primary colonic adenocarcinoma had significantly 
more of the vitamins, riboflavin, B6, nicotinate, pantothenate, thiamin, biotin and folates, 
whereas the concentration of Bn was almost half that of adjacent normal tissue. They 
suggested that those tumours with a high vitamin requirement for enhanced growth may be 
arrested with antivitamins targeted at metabolic sites. Perhaps some of the protective 
mechanism of vitamin deficiency is due to starvation in the rapidly multiplying tumour of the 
flavin coenzymes vital for metabolism These, apparent inhibitoiy effects of riboflavin 
deficiency have not been fully elucidated.
It is difficult to identify whether inhibition of growth rate of some tumours may be due to a 
change in calorie intake and body weight or due to a direct effect of riboflavin deficiency 
(Rivlin, 1975). In the experiment by Morris (1947) the caloric intake was approximately the 
same in both groups. Tannenbaum and Silverstone (1953) in an extensive review of the 
literature, came to the conclusion that varying the level of the B vitamins in the range above 
minimal needs had little effect on carcinogenesis. Rao et al. (1987) found that a 10-20 
percent reduction in body weight decreased the incidence of some tumours such as benign 
mammary tumours in the rat, but did not decrease the incidence of liver tumours.
1.6.3 Riboflavin Defidency as a Potentiating Factor in Experimental Carcinogenesis 
In contrast to spontaneous and transplanted tumours, there have been reports of potentiation 
of carcinogenesis by riboflavin deficiency, especially those induced by azo dyes.
Kensler et al. (1941) reported some protection from liver cirrhosis and cancer by riboflavin in 
the rat. Miller et al. (1941) studied the effects of modifying the diet on the rate of hepatic
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tumour formation due to DMBA (7,12-dimethylbenzanthracene). In general, the protective 
supplements were rich in protein and vitamin B complex especially riboflavin. There has been 
a suggestion that excess riboflavin protects against hepatomas induced by 
4-dimethylaminoazobenzene dye (DAB). It has been proposed that excessive riboflavin 
enhances the activity of the enzyme, azoreductase which degrades the azo dyes. Lambooy 
(1976) found if a small amount of riboflavin was added to a diet with a hepatic carcinogen 
for 18 weeks, carcinogenesis was strongly inhibited and 80 percent of rats did not develop 
hepatomas.
Schaefer et al (1950) described the influence of variations in dietary levels of riboflavin, 
pyridoxine, inositol and protein depletion-repletion on the incidence of tumours induced in 
rats by choline deficiency. Neoplasms were found in all groups apart from a group of eight 
rats supplemented with 20mg of riboflavin/kg of diet. There also appeared to be less severe 
cirrhosis induced. Robertson and Kahler (1942) compared the riboflavin content of primary 
and transplanted hepatomas with rapidly growing non-neoplastic tissue of similar origin and 
found it to be below that of non-neoplastic liver.
Chan et al (1972) demonstrated that the skin and livers of mice fed a riboflavin deficient diet 
had a much lower than normal activity of microsomal aryl hydrocarbon hydroxylase. This is 
part of the microsomal enzyme complex which metabolises a variety of exogenous chemicals 
including carcinogens, drugs and pesticides. Yang (1974) also demonstrated changes in this 
enzyme system in riboflavin deficiency. This system has also been considered a detoxification 
system Some of the effects may be due to the fact that flavin cofactors are involved in drug 
and carcinogen metabolism (Rivlin, 1982). Riboflavin is involved in the electron transport
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chain and lipid metabolism and also assists in the degradation of drugs and foreign chemicals 
via microsomal hydroxylation (Rivlin et al., 1983).
Roe (1962) attempted to reduce the incidence of experimental skin carcinomas in mice by 
administering massive doses of riboflavin and other B group vitamins. Riboflavin had no 
more than a slight inhibitory effect while other vitamins of the B group had no definite effect. 
While Wynder and Klein (1965) felt that the early epithelial changes detected in the 
oesophageal and stomach mucosa of riboflavin deficient mice could not be attributed to 
riboflavin deficiency alone, but rather to starvation, in later experiments Wynder and Chan 
(1970) found that pure caloric restriction did not affect tumour induction. They compared 
the induction of skin tumours due to local application of DMBA and croton oil between mice 
fed a normal diet and those that had been fed a riboflavin deficient diet for four weeks. Skin 
tumours were found to develop sooner, and in greater numbers than the controls. 
Joseph-Bravo et al. (1976) carried out an experiment looking at the effects of artificial light 
and riboflavin on the toxicity of aflatoxin. They demonstrated that light decreased the 
incidence of aflatoxin induced cancer. Aflatoxin caused blood riboflavin levels to decrease 
and this was enhanced by irradiation, suggesting that photosensitised riboflavin and aflatoxin 
form a complex thereby inhibiting its degradation into carcinogenic metabolites.
More recently, it has been suggested that riboflavin has a potential chemopreventive role due 
to its modulation of carcinogen-induced DNA damage and repair enzyme activity (Webster 
etal, 1996).
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Riboflavin as a “protective factor” would appear to be due the role of flavin dependent 
enzyme systems which inactivate the azo dyes and may have a role in metabolising and 
degrading a number of potential carcinogens. It may also be that the aforementioned effects 
of riboflavin deficiency on the epithelium makes it more prone to carcinogenesis.
1.6.4 Riboflavin and Cancer in Man
The majority of the human studies have centred on the relationship between riboflavin 
deficiency and oesophageal cancer. This is discussed further in Section 1.7.4. It has been 
proposed that in man, other neoplasms may be sensitive to riboflavin deficiency. Lane and 
Smith (1971) induced riboflavin deficiency in a small number of patients with Hodgkins 
disease, lymphosarcoma and polycythemia vera by giving them a synthetic diet and the 
riboflavin antagonist, galactoflavin. They managed to bring about partial remission of 
tumours in one of two patients with Hodgkin’s disease and two of four with lymposarcoma. 
However, treatment times varied between 24 and 152 days and the concentration of 
galactoflavin also varied. Patient numbers were small and concomitant treatment was not 
taken into consideration. It may have been expected in the diseases from which these patients 
were suffering that periods of remission would be expected.
The major carriers of riboflavin have been identified as immunoglobulins. Plasma of 182 
patients with different malignant diseases was tested for riboflavin binding. There was a 
significant increase in riboflavin binding immunoglobulins in those suffering from breast 
cancer and melanoma compared with controls. This may mean that these immunoglobulins 
maintain more riboflavin in the circulation which is then available for tumour tissues (Innis et 
al., 1986). These elevated levels may contribute to the lower urinary levels and clearance of
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riboflavin in cancer. This may also imply that if urine has been used as the body fluid to be 
monitored for riboflavin levels, there may be a false impression of the true body stores.
1.7 RIBOFLAVIN AND ORAL AND OESOPHAGEAL CANCER
1.7.1 Introduction
There have been a number of large epidemiological studies aimed at detecting a link between 
riboflavin deficiency (amongst other micronutrients) and oesophageal cancer. Oesophageal 
and oral cancer share some aetiological factors such as smoking and alcohol ingestion. In the 
study by Wynder and Klein (1965) similar histological changes were noted to occur in 
oesophageal and oral mucosa. They are likely due to their anatomical juxtaposition to be 
subjected to the same carcinogens and are both squamous epithelium. As there is little 
reference in the literature to the role of micronutrients in oral carcinogenesis, it would seem 
worthwhile to review some aspects of carcinoma of the oesophagus.
1.7.2 Incidence of oesophageal cancer
There is a 500 fold difference in rates of oesophageal cancer in different parts of the world 
(Ghadirian et al., 1988). This appears to be associated with differences in alcohol intake, 
tobacco usage, socioeconomic group and poor diet especially of vitamins A, C and B2. 
Carcinoma of the oesophagus accounts for approximately 25,000 deaths annually in Europe 
(approximately 5 percent of all carcinomas), whereas that from oral carcinoma accounts for 
approximately 2 percent in Western Europe (Soames and Southam, 1993). The 5 year 
survival rate is reported to be 5 percent (Krevsky, 1995). Men, are in the main, affected 
more commonly than women except in Scandinavia, UK and India (Mandard, 1989). There
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is a high incidence in the Middle East, especially North-East Iran (Warwick and Harington, 
1973).
In China, especially in the North, 2000 year old records mention a "dysphagia” syndrome in 
Henan province and in T Inxian ge shi bing or "hard of swallowing disease" has long been 
endemic. There has even existed a "Throat-God Temple" (Yang, 1980). Due to the high 
incidence of the disease in China, epidemiological studies were initiated in 1959. In the 
Linxian area 20 percent of the total deaths were due to oesophageal cancer.
1.7.3 Aetiology of Oesophageal Cancer
Many aetiological factors have been implicated in the development of oesophageal cancer, 
such as alcohol, tobacco, opium, nutritional deficiencies, malabsorption and chronic irritation, 
to name but a few (Cook-MozafFari et al., 1979: Ghadirian et al, 1985)). Physical damage 
due to hot liquids and hard foods has also been implicated (Martinez, 1969). Pickled 
vegetables are often consumed in areas with a high incidence of oesophageal carcinoma and 
the feet that chickens in these areas also suffer from a high incidence of gullet cancer suggests 
"common carcinogens" (Ghadirian et al., 1988; Yang, 1980). N-Nitroso compounds 
including N-nitrosamines have been implicated in oesophageal cancer (Lu and Lin, 1982: Lu 
etal., 1986).
A low intake of fresh fruit and vegetables has been implicated (Cook-Mozafferi et al., 1979: 
Guo et al., 1990: Hormozdiari et al, 1975). In areas where sundried food are the norm, 
riboflavin levels may be severely affected. As previously mentioned, riboflavin levels drop
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after exposure to sunlight. In contrast to oral carcinoma, the study by Guo et al (1990) failed 
to link the incidence of oesophageal cancer to alcohol intake or tobacco usage.
Franceschi et al. (1990) examined patients with oral, pharyngeal and oesophageal cancer 
from Pordenne Province in North East Italy where there is a high incidence of these 
neoplasms. There appeared to be a significant association between maize consumption and 
the incidence of neoplasms. These differences could not be explained in terms of education, 
occupation, tobacco use or consumption of fruit or vegetables. Maize increased the risk if the 
patients consumed more than 42 drinks per week. It was suggested that the effects were due 
to maize causing deficiencies of micronutrients such as niacin and riboflavin. Deficiencies of 
micronutrients have been found in plants in the gardens patients suffering from oesophageal 
cancer (Burrell et al., 1966). Maize was prone to attack by two fungi toxic to animals., 
leading to the formation of nitrosamines.
Much of the research into carcinoma of the oesophagus has taken place in Iran due to the 
high incidence of the disease in that country. Oesophagitis has been implicated as an 
aetiological factor (Crespi et al., 1979). A population survey in a high risk area for 
oesophageal carcinoma in Russia, showed that 60 percent of those who had 
oesophagogastroscopy had chronic oesophagitis (Zaridze et al., 1985b).
Just as is the case with oral cancer, it would seem that there is no single factor responsible for 
oesophageal cancer. It may be, that it is due to deficiencies in the diet making the mucosa 
more vulnerable to carcinogens.
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Paterson-Kelly syndrome (or Plummer-Vinson syndrome) is associated with oesophageal 
cancer. It appears to occur in females with a history of anaemia and dysphagia (Ahlbom, 
1936). Riboflavin has been implicated as a deficiency factor although in one group of 25 
patients, no evidence was found that riboflavin deficiency was an important factor in this 
condition and it did not appear to play a part in causing the associated oral lesions. There was 
evidence of pyridoxine deficiency (Jacobs and Cavill, 1968b). Wynder et al. (1957) carried 
out a survey to elucidate the causes of cancer of the upper alimentary and respiratory tracts 
in Sweden. There was a close relationship between Plummer Vinson syndrome and 
carcinomas of other sites. The high incidence may have been due to the high incidence of 
Plummer Vinson syndrome in Sweden. Apart from iron deficiency being a primary factor it 
was thought that other deficiencies were also involved although they were not specified. As 
riboflavin is involved in the metabolism of iron, a deficiency in riboflavin may indirectly 
influence the incidence of the syndrome.
1.7.4 Riboflavin Deficiency in Relation to Oral and Oesophageal Cancer 
Riboflavin deficiency has been implicated in both oral and oesophageal cancer. It may be, that 
certain deficiencies are associated with increased susceptibilities to oral and oesophageal 
cancer. Low levels of riboflavin have been found in several populations with a high incidence 
of oesophageal cancer (Zaridze et al., 1985a: Thumham et al., 1985). In Linxian in Northern 
China, there was a very high mortality rate from oesophageal cancer. Yang et al. (1984) 
analysed the nutritional status of the population of the area and found riboflavin deficiency 
was present in 90 percent of subjects. Thumham et al, (1985) in the same population found 
low levels of riboflavin in those with oral leukoplakia. While low levels of riboflavin have 
been found, treatment with micronutrients has had mixed results. Munoz et al. (1985) treated
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subjects with retinol, riboflavin and zinc for one year, but no differences in the incidence of 
oesophagitis, atrophy or dysplasia were found. It was suggested that the reason for failure to 
detect changes could have been due to the treatment period being too short or the doses 
being too small. However, a later examination of a subsample of 200 subjects to evaluate 
micronuclei formation of cells in the buccal mucosa and oesophagus found a significant 
reduction in the frequency of micronucleated cells in the oesophageal mucosa, but not the 
buccal mucosa (Munoz et al., 1987).
Rather than testing populations for deficiency, a number of workers rely on questioning 
populations as to previous intake of nutrients or extrapolate that recent dietary habits 
correctly reflect previous intake. This is notoriously unreliable. Ziegler et al. (1981) 
questioned the next of kin of 120 black male residents of Washington who had died of 
oesophageal cancer and correlated estimates of intake of vitamin A, carotene, vitamin C, 
thiamin and riboflavin as being inversely associated with relative risk, but as broad food 
groups rather than as each micronutrient. Analysis of the intake of populations in the 
Transkei demonstrated less than two thirds of the recommended dietary requirements of 
nicotinic acid, riboflavin and ascorbic acid were consumed in those with a high frequency of 
oesophageal cancer (Groenewald et al., 1981).
The effects of oestrogen on riboflavin excretion were examined in a group of patients with 
oral cancer (Sathe et al., 1958) The excretion levels of thiamine and riboflavin were lower 
than normal in cancer patients whereas excretion levels of oestrogen were higher. If these 
vitamins were administered, it led to an increase in the excretion of oestrogens in the cancer 
patients, but not in the controls. Administration of oestrogen on the other hand decreased
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levels of thiamine and riboflavin. It was concluded that oestrogen treatment appeared to be 
harmful in men with oral cancer as it induced thiamine and riboflavin deficiencies.
Water contaminated with calcium, magnesium, chromium, cadmium, cobalt and traces of 
petroleum oil has been implicated in oesophageal cancer in a study of the Gassim region of 
Saudi Arabia (Amer et al., 1990). As mentioned previously some of these elements are 
thought to chelate with riboflavin and may bring about deficiency (Cooperman and Lopez, 
1984).
1.8 AIMS OF THE THESIS
As can be seen, there is conflicting evidence as to the role of riboflavin in cancer. Population 
studies may give some pointers to possible aetiological factors in cancer of the oesophagus 
and oral cavity, however, the links are all too often tenuous. It is impossible to separate out 
the multifactorial nature of carcmognesis in the general population There are a few studies 
reporting effects of riboflavin deficiency on epithelium, but there is little or no information 
regarding quantitative histology of the epithelial changes. In addition, most of the early 
studies fail to adequately monitor riboflavin levels throughout the experimental period.
The aim of the studies reported in this thesis was to investigate the effects of riboflavin 
deficiency on oral epithelium Because of the difficulty in studying simple nutrient deficiencies 
in man, an experimental animal study was undertaken. It was intended that future studies 
would progress to investigation of experimental carcinogenesis and therefore the hamster, 
with the well characterised cheek pouch model, was selected as the experimental animal The
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series of experiments included establishment of tests to detennine normal riboflavin values 
for the hamster; administration of an experimental diet deficient in riboflavin with monitoring 
of riboflavin levels throughout the experiment; and the quantitative evaluation of oral 
epithelial changes in the experimental riboflavin deficient group compared to a control group.
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CHAPTER 2
RIBOFLAVIN TESTING IN HAMSTERS- A PILOT STUPY AND 
OPTIMISATION OF THE ERYTHROCYTE GLUTATHIONE REDUCTASE 
TEST FOR HAMSTER BLOOD
2.1 INTRODUCTION
The hamster was the chosen experimental animal Previous work has been carried out on the 
manipulation of the hamster diet resulting in various nutritional deficiencies. However, little 
has been reported in relation to riboflavin deficiency. Riboflavin appears to be a nutritional 
requirement in the hamster. Riboflavin deficiency can be induced in the hamster by dietary 
manipulation. Riboflavin can be excluded from the diet or an antagonist such as galactoflavin 
can be used. Salley and Weatherred (1964) fed hamsters a riboflavin deficient diet and using 
a microbiological assay, demonstrated significantly lower riboflavin levels in the hamster liver 
after seven weeks. Kim and Roe (1985) experimented with hamsters fed diets with varying 
levels of riboflavin and alcohol They monitored the levels by the erythrocyte glutathione 
reductase assay, which is the most commonly used method of monitoring riboflavin levels in 
humans. Kim and Roe (1985) did not report any technical problems using hamster blood, but 
as only small amounts of blood can be removed regularly from hamsters it was decided to 
determine whether the laboratory scheduled to carry out erythrocyte glutathione reductase 
testing was able to obtain reliable data from the small amounts of blood available.
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2.2 MATERIALS AND METHODS
2.2.1 Animals
Seven, young aduk Syrian hamsters were used in the pilot study. They were fed on standard 
hamster diet and appeared completely healthy during the experimental period. The animals 
were bled four times at intervals of four weeks and were sacrificed on the twelfth week.
2.2.2 Collection of Blood Samples
Collecting repeated blood samples from laboratory animals can be problematical In the rat 
the tail vein can be used and in the rabbit the ear vein. Unfortunately neither option is suitable 
in the hamster as the superficial veins are small and the tail is rudimentary. Cardiac puncture 
can be used, but is unsuitable for repeated sampling in an individual animal because even in 
the best circumstances there is an associated high mortality. Pansky et a l (1961) described a 
technique for obtaining blood from the retro-orbital sinus in the hamster and this provides the 
only practicable method for repeated sampling in the individual animal.
Bleeding was undertaken using a 2ml syringe with a 15mm long needle of 0.5mm diameter. 
Hamster blood clots very readily and to avoid this a small volume of 1:1000 heparin solution 
was drawn into the syringe and then expelled shortly before bleeding. Using the Pansky et al 
(1961) technique, the aim was to remove 1ml of blood from each of the seven animals on 
three occasions. At the time of sacrifice a larger volume was collected by cardiac puncture 
following a lethal overdose of NembutaL All blood samples were placed in standard lithium 
heparin containers and were analysed by the Biochemistry Department of Glasgow Royal 
Infirmary
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2.2.3 Technique of Riboflavin Analysis
The enzymatic method is the most commonly used test for riboflavin levels in hospital 
laboratories. This test appears to be the most reliable although one result should not be 
looked at in isolation, but rather as a series of results. There are numerous variations to the 
technique, using a variety of concentrations of reagents. The technique used at Glasgow 
Royal Infirmary is the erythrocyte glutathione reductase test as described by Delides et al 
(1976). The enzyme exists in both inactive and active forms. FAD converts the inactive to 
the active form and the active form then reduces oxidised glutathione with a corresponding 
oxidation of NADPH The amount of NADPH which is oxidised is monitored optically at 
340 nm and therefore the degree of activation is calculated which gives an indirect measure 
of riboflavin status. The percentage activation is calculated from the following 
equation:- % activation = (GR activity with FADxlOO) - 100
GR activity without FAD 
In humans a percentage activation of greater than 60 indicates riboflavin deficiency and there 
are no reports in the literature that suggest a different threshold for hamsters.
2.3 RESULTS
2.3.1 Health of the Animals
Throughout the experimental period, none of the animals showed any sign of distress and 
there appeared to be no problems with the orbital area following each bleed. There were no 
features to suggest nutritional deficiency.
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2.3.2 Blood Samples
Difficulty was experienced in removing adequate amounts of blood for testing due to the 
operator's inexperience in the technique. A sufficient volume was not always obtained on 
each occasion.
2.3.3 Riboflavin Levels
The results of the riboflavin assessment in the pilot study are shown in Table 2.1. Where 
there is no result listed, there was insufficient sample to carry out the analysis. In the human 
subject, if the percentage activation is greater than 60 percent there is thought to be 
deficiency. There appeared to be one result which suggested riboflavin deficiency and that 
was in hamster seven on the first bleed. Thereafter, however, the results for the animal 
showed no sign of deficiency. It is advised in humans, to carry out serial testing due to the 
inconsistency of the results and this appeared to be bome out in this pilot study. Insufficient 
blood for analysis was collected from animals 2 and 4 on the first bleed and from animal 5 on 
the second bleed. The samples from the second bleed were analysed twice to check for 
reproducibility. As can be seen there was some variability. This may have been due to slight 
differences in dilutions and handling of the samples. As mentioned previously, riboflavin 
testing, even in man is variable. One of the problems involved in testing hamster blood is that 
hamster blood clots readily, although this was not a problem in this pilot study. The largest 
volume that could be supplied to the laboratory was 1ml of sample and usually it was 0.5ml 
or less, thus making the handling of the sample more difficult. However it was hoped that as 
experience was gained with the retro-orbital bleeding, more consistent sampling up to 1ml of 
blood would be achieved.
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Alternative methods of riboflavin testing were considered. The use of high performance 
liquid chromatography was considered. No laboratories approached considered this as 
appropriate and the technique would normally require 2-3ml of blood.
HAMSTER WEEK1 WEEK4 WEEK8 WEEK12
1 4 33 16 12 33
2 - 18 20 5 38
3 4 37 21 35 27
4 - 31 19 16 7
5 33 - 25 31
6 4 54 39 21 6
7 62 7 7 28 25
Table 2.1 Riboflavin results of pilot study. Units are percentage activation
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2.4 OPTIMISATION OF THE ERYTHROCYTE GLUTATHIONE REDUCTASE
TEST FOR HAMSTER BLOOD 
Due to the inconsistent results for riboflavin levels obtained from the laboratory at Glasgow 
Royal Infirmary in the pilot study and in further experiments (Carmichael and MacDonald, 
1992), it was decided to change laboratories and to develop testing of riboflavin using the 
same basic method of the erythrocyte glutathione reductase (EGR) test, but optimised for 
hamster blood. This was carried out in the Biochemistry Laboratory at the Victoria 
Infirmary, Glasgow.
2.4.1 Technique
It was decided to utilise the modifications of the EGR test as described by Thumham and 
Rathakette in 1982. This technique was based on the method described by Glatzle et al. 
(1970). It was found when analysing samples of a quality controlled haemolysate at the 
beginning and end of each batch of samples over a 20 week period that the activation 
coefficient (AC) was higher at the end of a batch than at the beginning (Thumham and 
Rathakette, 1982). It was felt that this was due to suboptimal conditions of the assay. 
Maximum coupling of FAD to glutathione reductase (NAD(P)H2: glutathione 
oxidoreductase; EC 1.6.4.2) occurred with an incubation of 15 minutes at 35° rather than 5-7 
minutes as used by most workers. As an alternative, if batches of sample are used, the 
enzyme and FAD could be preincubated in the reaction mixture for 2 hours at 4° or 1 hour at 
25° before incubating for the standard 5 minutes at 35°. There was a slight deterioration of 
quality control results after 4 weeks, but even over a 20 week period the results remained 
within 2 standard deviations of initial values.
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2.4.2 Optimization for the Hamster Model
Familiarisation with the technique was achieved using blood from human volunteers. 
Following this, blood samples from normal hamsters were tested. Three normally fed, 
healthy, Syrian hamsters were sacrificed and bled by cardiac puncture in order to obtain the 
maximum amount of blood for analysis. As previously described, heparinised needles and 
syringes were used and the blood was transported in lithium heparin containers. It soon 
became apparent that ham ster blood had a much lower level of activity than human blood 
and therefore a variety of different concentrations of the reagents were tested to find the 
optimal conditions. Glutathione reductase catalyzes the reduction of oxidised glutathione 
(GSSG) with simultaneous oxidation of nicotinamide-adenine dinucleotide phosphate 
(NADPH). A measure of enzyme activity is provided by the rate of absorbance decrease at 
340nm This activity is then expressed as U/g of haemoglobin in the haemolysate.
Samples from the three animals were tested using combinations of [FAD] of 6, 8 and 
10mmol/l;[NADPH] of 40, 80, 100, 120, 160 and 200mmol/l; [Ox. Glutathione] 1 and 
2mmol/L All reagents were supplied by Sigma.
Once the optimum concentrations of all the reagents had been determined, samples from nine 
hamsters which were being sacrificed for other reasons were also tested and riboflavin levels 
ascertained. In order to establish a normal range of riboflavin levels, the initial samples from 
the 25 animals used in the experiment reported in Chapter 3 were also included giving a 
larger sample size. Quality control samples of hamster blood were included in each batch.
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The haemolysate was prepared by centrifuging the venous blood at 3000 rpm for five
minutes. The plasma and buffy layer were then pipetted off and discarded and the
haemolysate was prepared by mixing equal volumes of red cells and water. These were
vortex mixed and then frozen to -20°C. Potassium phosphate buffer was prepared by mixing
18.42g of K2HPO4.3H2O and 2.61g KH2PO4 made up to 1 litre in distilled water with lg of
K2EDTA added giving a pH of 7.4. FAD was prepared by mixing 2.488g with 10ml buffer.
The optical density of FAD was read at 450nm and the concentration calculated from
c = A 
11300
Oxidised glutathione was prepared by mixing 109mg in 100ml buffer. NADPH was prepared 
by mixing 20.84mg in 50ml buffer. The frozen haemolysate was then defrosted and 50ml of 
the haemolysate and 950ml of buffer were vortex mixed. The Cobas-Bio Analyser (Roche 
Diagnostic Systems) was then programmed to use a total volume of 250 ml made up of 
40ml sample, diluent in the form of water of 10ml, GSSG of 150ml and NADPH of 50ml. 
Cuvettes were set up with 120ml haemolysate with every two cuvettes having 20ml buffer or 
20ml FAD. Haemoglobin measurements were carded out on a 2500 Co-oximeter 
(CIBA-CORNING). The cuvettes were incubated at 37°C for 15 minutes. The activity of 
glutathione reductase were measured before and after the addition of FAD, respectively, by 
spectrophotometric determinations of NADPH oxidation. The activation coefficient (AC) 
was derived by dividing the stimulated EGR activity + FAD by basic EGR activity. Results in 
humans of less than 1.3 are regarded as normal, 1.3 to 1.5 as marginal deficiency and those 
above 1.8 as severe deficiency.
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2.5 RESULTS
2.5.1 Optimum concentrations of reagents
The optimum concentrations of reagents decided upon were [FAD] 8.0mmol/l, [NADPH] 
100mmol/l and [Ox. glutathione] 1.0 mmol/1.
2.5.2 Normal values
34 samples were analysed using the above concentrations. The EGR activity with and 
without FAD was obtained, EGR activity with and without FAD per g/dl of haemoglobin 
was calculated and the activation coefficient then obtained. EGR activity was much lower in 
hamster blood than in human blood, being less than 20 compared with more than 30 in 
humans. Activation coefficients for the 34 animals are shown in Tables 2.2 and 2.3. The 
values ranged from 0.92 to 1.23. The mean value for the 34 animals was 1.06 with a 
standard deviation of 0.07. The values for all animals lay within the range +/- 2.5 standard 
deviations of the mean. This would suggest an activation coefficient of greater than 1.24 is 
indicative of riboflavin deficiency in the hamster. The reliability of the test was satisfactory 
with the quality control for hamster blood over the experimental period having a mean 
activation coefficient of 1.05 and standard deviation of 0.04. The enzymatic activity of all the 
quality control samples fell over the experimental period, although it always remained within
2.5 standard deviations of the initial sample. Each quality control sample was tested twice in 
a session, at the beginning and end of batches. The intra batch variation never exceeded 2 
standard deviations.
Only one animal gave a result which approached biochemical deficiency, but as mentioned 
earlier, results should not be looked at in isolation and repeated sampling is indicated.
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2.6 CONCLUSIONS
Using this technique, even small amounts of sample can be tested for riboflavin levels. It was 
felt that by carrying out the testing ourselves the samples would be handled with more care 
and perhaps more consistent results would be obtained. It was also felt that the results would 
be more meaningful as the reagents were now optimised for the testing of hamster blood.
Animal EGR
ACT
EGR+FAD
ACT
EGR
ACT/Haem
EGR+FAD
ACT/Haem
AC
1 14.15 14.89 2.00 2.11 1.05
2 11.57 11.48 1.69 1.67 0.99
3 14.05 14.19 1.92 1.94 1.01
6 8.50 9.99 1.38 1.62 1.18
7 8.33 9.98 1.28 1.53 1.20
8 7.33 8.09 1.17 1.29 1.10
9 7.99 9.79 1.27 1.55 1.23
10 8.75 9.12 1.33 1.39 1.04
11 9.41 10.45 1.35 1.51 1.11
Mean 10.05 10.89 1.49 1.62 1.10
SD 2.7 2.23 0.3 0.26 0.03
Table 2.2 Riboflavin levels of normal hamsters
EGR ACT = eiythroctye glutathione activity
EGR+FAD ACT=erythrocyte glutathione + FAD activity
EGR ACT/Haem= erythrocyte glutathione activity per gram of Haemoglobin
EGR+FAD ACT/haem=erythrocyte glutathione + FAD activity per gram of haemoglobin
AC=activation coefficient
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Animal EGR
ACT
EGR+FAD
ACT
EGR
ACT/Haem
EGR+FAD
ACT/Haem
AC
1 8.59 9.23 2.82 3.03 1.08
2 9.92 10.04 3.13 3.17 1.01
3 12.04 11.08 2.03 1.87 0.92
4 11.43 11.93 3.00 3.13 1.04
5 8.45 9.95 3.34 3.93 1.18
6 16.83 16.87 2.82 2.83 1.00
7 13.65 13.67 2.51 2.51 1.00
8 6.61 6.85 2.85 2.96 1.04
9 9.64 9.74 2.32 2.34 1.01
10 9.20 9.92 2.21 2.39 1.08
11 17.53 17.10 3.10 3.02 0.98
12 13.97 14.58 2.47 2.58 1.04
13 10.14 11.11 2.39 2.62 1.10
14 8.54 10.11 2.05 2.43 1.18
15 16.85 17.13 2.95 3.01 1.02
16 15.79 15.51 2.67 2.62 0.98
17 12.80 13.23 2.84 2.94 1.03
18 15.88 16.45 2.72 2.82 1.04
19 12.46 12.33 2.57 2.55 0.99
22 5.78 6.11 1.87 1.98 1.06
23 10.10 10.58 2.68 2.81 1.05
24 14.08 14.57 2.71 2.81 1.03
26 15.49 16.05 3.04 3.15 1.04
27 14.79 15.46 3.16 3.31 1.05
28 16.52 16.65 3.11 3.13 1.01
MEAN 12.28 12.65 2.69 2.80 1.04
SD 3.45 3.28 0.39 0.43 0.06
Table 2.3 Initial riboflavin levels of hamsters from Chapter 3. Legend as for table 2.2
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CHAPTER 3
RIBOFLAVIN DEFICIENCY IN THE HAMSTER MODEL AND ASSOCIATED 
ORAL EPITHELIAL CHANGES
3.1 AIMS
Previous studies had led us to believe that the posterolateral surface of the lingual epithelium 
was significantly reduced in length and in thickness of the cellular compartment in a group of 
hamsters fed a riboflavin deficient diet. A greater cell density was also found in progenitor 
areas (Carmichael and MacDonald, 1992). However, problems with the health of the animal s 
meant that it was likely they had been suffering from multiple vitamin deficiencies. In 
addition, riboflavin results were inconsistent. Now that an optimised technique of riboflavin 
testing had been developed, the aims of this part of the study were to induce riboflavin 
deficiency in a group of hamsters; to monitor the riboflavin levels throughout the 
experimental period using the optimised erythrocyte glutathione reductase test and to 
determine if any oral epithelial changes were demonstrable in association with the riboflavin 
deficiency. In particular, to ascertain whether earlier findings were a true reflection of the 
effect on oral epithelium of riboflavin deficiency.
3.2 MATERIALS AND METHODS
3.2.1 Animals
Twenty five young adult male Syrian hamsters were used in the experiment. These were 
divided into an experimental group of 15 animals and a control group of 10 animals. Due to 
the early deaths of some of the animals, a further three animals were recruited into the 
control group. They were housed in the animal house of the Anatomy Department of
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Glasgow University, and were obtained from their inbred colony. There was no evidence of 
vitamin deficiency prior to commencing the experiment and the colony had no history of 
large outbreaks of "wet tail". The animals were caged individually in plastic containers. In 
order to avoid the possibility of riboflavin being obtained from organic bedding material, 
absorbant non organic bedding material was used to cover the base of each cage. The 
animals were weighed regularly throughout the experimental period.
3.2.2 Diet
The experimental animals were fed a commercially obtained riboflavin deficient diet (Special 
Diet Services, Lavender Mill, Manea, Cambridgeshire, PE 15 OLU) while the control animals 
were fed the same diet with a higher riboflavin content. The requested levels of riboflavin 
were <lmg/kg and >15mg respectively. The recommended riboflavin levels are 12-20 mg/kg 
of diet. The diet was obtained as a powder which was mixed with a small amount of water to 
provide a thick paste. Animals were given fresh diet each morning in amounts which 
exceeded the daily intake and water ad libitum.
3.2.3 Bleeding
Up to 1ml of blood was removed at the start of the experiment on week 0 and then on weeks 
5 and 11 using the technique described previously in Section 2.2.2. The anaesthetic agent 
used on these occasions was Halothane. At sacrifice, blood was removed by cardiac puncture 
in order to obtain the greatest amount of blood possible for analysis.
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3.2.4 Technique of Riboflavin Analysis
All the blood samples were taken in lithium heparin containers to the Biochemistry 
Laboratory at The Victoria Infirmary, Glasgow for analysis as described in Chapter 2.
3.2.5 Killing of Anim als and Preparation of Sections for Analysis
The animals were deeply anaesthetised using Halothane and blood was obtained by cardiac 
puncture. The animals were then killed by cervical fracture. Following sacrifice, the heads 
were prepared, prior to placement in 10 percent formal saline. The tip of the tongue was 
removed from each animal in order to allow the remainder to he undistorted in the oral cavity 
during fixation. This assisted in the standardisation of the sections taken from tongue. The 
jaws were propped open by a rubber bung placed between the teeth again to minimise the 
distortion effects on the tongue.
Following fixation, the tongue was dissected out and blocks were taken from the posterior 
part where the lateral sides merged with the floor of the mouth and from the body of the 
tongue which was halved into dorsal and ventral portions. (Fig 3.1) The tissue blocks were 
paraffin processed. The blocks were cut at 4pm and haematoxylin & eosin stained sections 
were prepared. In order to obtain consistent sampling the sections of dorsal and ventral 
tongue epithelia were cut from the keratinised surface down through the epithelium This 
standardised the compression effects and minimised splitting of the keratin layer.
3.2.6 Histological Analysis of Sections
Quantitative histological analysis was undertaken using computerised planimetry. This 
utilised a microscope, computer and bitpad. (Fig 3.2) The part of the microscope section to
62
be quantified, designated as a field, was delineated with an eyepiece graticule. A light spot on 
the bitpad mouse was projected into the microscope field using a drawing tube attachment. 
When this light spot was traced along or around elements of the section, the corresponding 
movements of the mouse were converted into lengths and areas recorded on the computer.
Three areas of the tongue were chosen for analysis, the posterior lateral surface, the dorsal 
and the ventral surfaces of the tongue. Large variations in the histology of oral epithelium 
occur within short distances in hamster tongue, therefore consistent sampling between 
animals was achieved by the selection of fields for quantification relative to anatomical 
landmarks.
The area to be measured on the posterior lateral aspect of tongue was that situated three field 
widths from the reflection of the epithelium of the floor of the mouth. The following three 
fields were then measured (Fig 3.3). Values from both sides were combined giving values for 
six fields for each animal The fields were delineated by the square in an eyepiece graticule 
and each area of epithelium was orientated such that the surface was parallel to the top of the 
graticule. The magnification used was x400. Fields were orientated to give columns, running 
through the epithelium at right angles to the mean epithelial surface. The lengths of the 
surface and basement membrane and the areas of the cellular and keratinised compartments 
were measured. The keratinised compartment, which was the stratum comeum, was usually 
simple to distinguish from the rest of the epithelium The cellular compartment was that 
between the basement membrane and the stratum comeum The width of the sampling 
square in the eyepiece graticule was 228pm The compartment area measurements were
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divided by the column width of 228pm to provide an estimate of mean compartment 
thickness, which it was felt was an easier parameter to envisage.
Compartment analysis of the dorsal (Fig 3.4) and ventral (Fig 3.5) surfaces was also carried 
out, measurements being taken of two adjacent fields commencing two fields widths, one 
each side of the midline. The field width used for the dorsal surface was 368pm and for the 
ventral surface 228pm These differences were due to the different characteristics of the 
areas. The dorsal surface was thicker and more convoluted due to the papillae and was 
assessed at a magnification of x250.
3.2.7 Compilation and Analysis
The mean for every parameter of each area in every animal was obtained. Therefore, the 
values for the parameters of the six fields measured in the posterior lateral surface of tongue 
were averaged and the mean used for further analysis. Four fields of dorsal and ventral 
surfaces of tongue were likewise averaged. Statistical analyses using the Mann-Whitney U 
test were used to compare the values for animals on the control and deficient diets.
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sides
Fig 3.1 Blocks from three areas o f the tongue were taken. These were the 
posterolateral aspect, and the body o f the tongue which was divided into dorsal 
and ventral halves.
Fig 3.2 Microscope, computer and bitpad used for the quantitative histological 
analysis.
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Fig 3.3 Measurements from the posterolateral surface of tongue were made 3 field 
widths from the reflection of the floor of the mouth. The following 3 fields were 
measured. The field width was 228 pm.
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Fig 3.4 Measurements from the dorsal surface of tongue were made 2 field widths 
from the midline. The following 2 fields were measured. The field width was 368 
jam.
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Fig 3.5 Measurements from the ventral surface of tongue were made 2 field 
widths from the midline. The following 2 fields were measured. The field width 
was 228 jam.
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3.3 RESULTS
3.3.1 H ealth  o f  the  Animals
Unfortunately, several of the animals failed to thrive and due to some early deaths three 
further animals were recruited into the control group. The animals were diagnosed as 
suffering from "wet tail". "Wet tail" refers to the appearance that results from diarrhoea and 
this may be caused by a variety of diseases, but is most often used synonymously with 
proliferative ileitis. This is a highly contagious disease most likely transmitted by the 
faecal-oral route and has an associated high mortality. Campylobacter species and 
Escherichia coli have been implicated in its aetiology and tetracyclines have been found to be 
most effective in the treatment of this infection (Frisk, 1987). Antibiotics are also known to 
affect riboflavin requirements (Cooperman and Lopez, 1984). Three animals in the 
e>q)erimental group and seven in the control group died prior to the end of the experiment. 
This meant that there were only 12 animals in the experimental group and six in the control 
group available for analysis. With the deterioration in health of many of the animals including 
the control group it was decided to terminate the experiment at week 11.
3.3.2 Weights
The weights of the animals are shown in Tables 3.1 and 3.2. There were no significant 
differences in the weights at the start of the experiment, week 5 or at sacrifice.
3.3.3  Riboflavin Levels
The riboflavin levels are shown in Tables 3.3 and 3.4. Deficiency was deemed to be present if 
the ratio was greater than 1.24. There was a trend towards deficiency in the experimental 
group, four of the 12 animals demonstrating biochemical deficiency at sacrifice. However,
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one of the six control animals also appeared to be biochemically deficient at sacrifice, 
although the two previous results for this animal did not suggest a trend towards deficiency. 
There were no significant differences in activation coefficients between the experimental and 
control groups at sacrifice although the experimental group had significantly higher activation 
coefficients at week five (p=0.01). The lack of difference at week 11 may have been due to 
the small number of control group animals. The animals suffering from "wet tail" may have 
suffered from reduced absorption of nutrients including riboflavin and as there were a greater 
number of those within the control group this may also have accounted for the lack of a 
significant difference in activation levels.
3.3.4 Histological Analysis of Posterolateral Surface of Tongue
These sections were analysed as described in Sections 3.2.5 and 3.2.6. The results are shown 
in Tables 3.5, 3.6, 3.7 and 3.8. There were no significant differences in the length of surface 
epithelium, length of basement membrane, thickness of the cellular compartment or thickness 
of the keratinised compartment. The ratios of keratinised compartment:total thickness and 
cellular compartment Total thickness were calculated and compared in order to ascertain 
whether the proportions were different. There were no significant differences.
3.3.5 Histological Analysis of Dorsal Surface of Tongue
These sections were analysed as described previously in Sections 3.2.5 and 3.2.6. The results 
are shown in Tables 3.9, 3.10, 3.11 and 3.12. There were no significant differences in the 
lengths of the epithelial surface, the lengths of the basement membrane or in the thickness of 
the cellular compartment. There was a significant difference in the thickness of the 
keratinised compartment, being significantly greater in the experimental group compared
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with the control group. (Mann Whitney U test p=0.04) There were no significant differences 
in the ratios of keratinised compartment thickness:total thickness or cellular compartment 
thickness:total thickness.
3.3.6 Histological analysis of Ventral Surface of Tongue
These sections were analysed as described in Sections 3.2.5 and 3.2.6. The results are shown 
in Tables 3.13, 3.14, 3.15 and 3.16. There were no significant differences in length of surface 
epithelium, thickness of keratinised compartment or thickness of the cellular compartment. 
There was a significant difference in the length of the basement membrane, this being greater 
in the experimental group (Mann Whitney U test p=0.046). There were no differences in the 
ratios, keratinised compartment:total thickness or cellular compartment:total thickness.
3.4 DISCUSSION
In this experiment, difficulty was experienced in producing biochemically deficient animals. 
Early on in the experiment there were significant differences in activation coefficients 
between the experimental group and controls. However, this was not the case at the 
conclusion of the experiment. Interestingly, the activation coefficients reported in the 
experiment by Kim and Roe (1985) followed a similar pattern, in that there was an initial 
increase in all groups over the first two to four weeks followed by a decrease over the next 
two to four weeks and finally, another increase over the last two weeks of the experiment. A 
significant difference in the activation coefficients between the groups fed a riboflavin 
deficient diet and those with riboflavin supplements (no alcohol) only occurred at week two. 
At the end of the experiment, while there was a trend towards a difference this was not
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significant. They considered refection as the most likely cause of the initial variation in values 
of activation coefficients. This is certainly a possible reason for the variation reported in this 
experiment as faeces were not collected.
Due to the problems encountered with the health of the animals including the control group, 
analysis of both diets was carried out to exclude possible bacterial contamination and to 
identify the nutritional components. The microbiology results indicated that there was no 
bacterial contamination likely to cause an enteric infection. The riboflavin content of the 
deficient diet was found to be 2.7mg/kg by Asp land and James Ltd (Independent Analytical 
Consultancy) and 1.4mg/kg by Special Diet Services. The control diet was found to have 
8.4mg/kg riboflavin by Aspland and James Ltd and 5.3mg/kg by Special Diet Services. These 
levels differed from the levels requested as the recommended dietary level of riboflavin for 
hamsters is 12-20mg/kg, although 6mg/kg has also been reported as satisfactory 
(Cooperman and Lopez, 1984) and the suppliers of the diet when contacted, quoted a range 
of 10-15mg/kg. It was concluded that the levels obtained were often lower than those 
expected due to the method of testing. A microbiological technique had been utilised. The 
levels reported were what they would expect following the addition of lOmg/kg of riboflavin 
to the base diet. This meant that the control animals may have received less than the 
recommended levels, therefore, there was not such a contrast between the two groups. This 
may account for the lack of flourishing of the control group, although if this was the only 
reason, it would have been expected that more of the experimental group would be affected.
The significant differences found in the thickness of the keratinised compartment of the 
dorsal surface of tongue and length of basement membrane of the ventral surfaces of
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tongue were only slight and have to be treated with some sceptism in view of the lack of 
attainment of convincing riboflavin deficiency in the experimental group. If the 
differences did truly represent the effect of riboflavin deficiency then it would seem that 
it causes a thickening of the keratin layer in the dorsal surface of tongue which could 
offer some protection against topical carcinogens and the increase in the basement 
membrane length of the ventral surface of tongue would suggest more pronounced rete 
ridges. This may also afford some protection. Foy et al. (1972) noted that baboons fed a 
riboflavin deficient diet, developed hyperkeratosis and thickened, branching rete pegs of 
the epidermis. These changes would be consistent with the changes noted in this 
experiment. In addition, Wynder and Klein (1965) when supplying mice a riboflavin 
deficient diet noted hyperkeratosis early on in the experiment and epithelial hyperplasia 
of the tongue in the seventh to ninth weeks. These changes are similar to the findings 
reported in this study.
73
Animal Week 0 Week 5 Final
1 82 75 90
2 82 84 89
3 80 79 87
4 73 78 79
5 50 88 101
6 69 83 87
7 72 83 90
8 68 93 102
9 68 81 95
10 67 86 99
11 77 84 89
12 89 89 88
13 62 67 75
14 64 75 60
15 79 77 74
Mean 72 81 87
SD 9.8 6.6 11.2
Table 3.1 Weights (g) of the animals in the experimental group. All the animals were alive 
at week 5. Due to the early deaths of animals 13, 14,15 they were excluded from any further 
analysis. The remainder of the animals survived to week 11.
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Animal Week 0 Week 5 Final
16 84 93 102
17 81 83 89
18 74 82 95
19 76 76 73
20 57 - 45
21 72 - 55
22 68 75 66
23 67 78 90
24 75 92 105
25 68 - 52
26 - 68 74
27 - 70 68
28 - 72 73
Mean 72 79 76
SD 7.7 8.6 19.2
Table 3.2 Weights (g) of the animals in the control group. Due to the early deaths of animals 
19, 20, 21, 22 and 25 which were excluded from further analysis, animals 26,27 and 28 were 
added at week 5. Animals 27 and 28 also died early and were also excluded from further 
analysis.
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Animal WeekO Week 5 Week 11
1 1.08 1.17 1.25
2 1.01 1.15 1.26
3 0.92 1.15 1.17
4 1.04 1.11 1.31
5 1.18 1.20 1.18
6 1.00 1.11 1.13
7 1.00 1.10 1.18
8 1.04 1.18 1.22
9 1.01 1.08 1.23
10 1.08 1.13 1.14
11 0.98 1.24 1.11
12 1.04 1.05 1.26
13 1.10 1.04 *
14 1.18 1.05 *
15 1.02 1.09 *
Mean 1.05 1.12 1.20
SD 0.07 0.06 0.06
Table 3.3 Riboflavin levels of the experimental group, which are recorded as an activation 
coefficient. Levels over 1.24 were considered to demonstrate deficiency.
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Animal WeekO Week 5 Week 11
16 0.98 1.07 1.23
17 1.03 1.03 1.25
18 1.04 1.10 1.02
19 0.99 1.02 *
22 1.06 1.07 *
23 1.00 1.11 1.00
24 1.03 1.14 1.20
26 * 1.04 1.14
27 * 1.05 *
28 * 1.01 *
Mean 1.02 1.06 1.14
SD 0.03 0.04 0.11
Table 3.4 Riboflavin levels in the control group, which are recorded as an activation 
coefficient. Levels over 1.24 were considered to demonstrate deficiency.
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Animal LSU LBM TKC TCC TOTAL
1 214.10 236.11 11.48 26.94 38.42
2 274.11 256.78 19.25 40.80 60.05
3 234.96 244.11 14.82 37.84 51.08
4 243.94 238.05 13.72 37.41 51.13
5 263.38 250.27 25.08 44.74 69.82
6 254.02 268.18 17.82 50.62 68.44
7 250.59 283.56 27.18 59.73 86.91
8 258.19 279.82 22.41 53.04 75.45
9 248.32 265.08 29.83 58.30 88.13
10 245.04 262.94 22.97 54.73 77.70
11 245.33 239.19 21.16 43.17 64.33
12 250.29 252.21 14.35 49.81 64.16
Mean 248.52 256.36 20.06 46.30 66.30
SD 14.83 15.94 5.77 9.86 14.83
Table 3.5 Quantitative histological analysis of epithelium from the posterolateral surface of 
tongue of the experimental group. The values LSU and LBM represent the mean surface 
length and basement length respectively for the six measured columns o f228 pm width. The 
thickness measurements of the keratmised compartment (TKC), cellular compartment (TCC) 
and the combination of these (TOTAL) are in pm
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Animal LSU LBM TKC TCC TOTAL
16 248.28 255.18 25.40 53.51 78.91
17 281.94 265.35 21.82 50.03 71.85
18 251.71 255.35 19.45 42.34 61.79
23 246.58 242.28 19.40 48.88 68.28
24 254.62 258.93 25.21 57.60 82.81
26 244.50 252.29 17.42 40.20 57.62
Mean 254.60 254.90 21.28 48.76 70.21
SD 13.87 7.64 3.09 6.59 9.70
Table 3.6 Quantitative histological analysis of epithelium from the posterolateral surface of 
tongue of the control group. The values LSU and LBM represent the mean surface length 
and basement length respectively for the six measured columns of 228 pm width. The 
thickness measurements of the keratinised compartment (TKC), cellular compartment (TCC) 
and the combination of these (TOTAL) are in pm
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Animal RATIO KER: TOTAL RATIO CELL:TOTAL
1 0.30 0.70
2 0.32 0.68
3 0.29 0.71
4 0.27 0.73
5 0.36 0.64
6 0.26 0.74
7 0.31 0.69
8 0.30 0.70
9 0.51 0.49
10 0.30 0.70
11 0.33 0.67
12 0.22 0.78
Mean 0.31 0.69
SD 0.07 0.07
Table 3.7 The mean ratios of the thickness of the keratinised and cellular compartments against 
the total thickness for the six measured columns of the posterolateral surface of tongue in the 
experimental group.
Animal RATIO KER:TOTAL RATIO CELL:TOTAL
16 0.32 0.68
17 0.30 0.70
18 0.31 0.69
23 0.28 0.72
24 0.30 0.70
26 0.30 0.70
Mean 0.30 0.70
SD 0.01 0.01
Table 3.8 The mean ratios of the thickness of die keratinised and cellular compartments against 
the total thickness for the six measured columns of the posterolateral surface of tongue in the 
control group.
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Animal LSU LBM TKC TCC TOTAL
1 595.47 921.63 54.88 109.53 164.41
2 628.43 725.35 64.03 100.16 164.19
3 523.33 556.53 64.06 110.01 174.07
4 527.99 832.69 59.72 128.19 187.91
5 680.44 707.75 67.84 115.51 183.35
6 607.25 758.97 48.33 99.15 147.48
7 599.77 772.98 51.24 109.27 160.51
8 665.02 743.17 54.49 105.79 160.28
9 500.21 830.06 54.02 119.07 173.09
10 570.62 815.22 56.60 121.37 177.97
11 564.66 698.75 59.36 108.24 167.60
12 638.37 783.01 48.28 101.54 149.82
Mean 591.80 762.18 56.90 110.65 167.56
SD 56.71 90.14 6.78 8.92 12.38
Table 3.9 Quantitative histological analysis of epithelium from the dorsal surface of tongue 
of the experimental group. The values LSU and LBM represent the mean surface length and 
basement length respectively for the four measured columns of 368 pm width. The thickness 
measurements of the keratinised compartment (TKC), cellular compartment (TCC) and the 
combination of these (TOTAL) are in pm
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Animal LSU LBM TKC TCC TOTAL
16 564.72 703.93 53.74 104.71 158.45
17 537.10 796.04 51.13 114.28 165.41
18 614.68 704.88 47.76 106.48 154.24
23 557.46 639.68 57.64 111.93 169.57
24 595.56 716.74 48.49 107.28 155.77
26 605.99 680.98 45.38 114.34 159.72
Mean 579.25 707.04 50.69 109.84 160.53
SD 30.66 51.47 4.46 4.21 5.88
Table 3.10 Quantitative histological analysis of epithelium from the dorsal surface of tongue 
of the control group. The values LSU and LBM represent the mean surface length and 
basement length respectively for the four measured columns of 368 pm width. The thickness 
measurements of the keratinised compartment (TKC), cellular compartment (TCC) and the 
combination of these (TOTAL) are in pm
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Animal RATIO KER:TOTAL RATIO CELL:TOTAL
1 0.34 0.66
2 0.39 0.61
3 0.37 0.63
4 0.32 0.68
5 0.37 0.63
6 0.33 0.67
7 0.32 0.68
8 0.34 0.66
9 0.31 0.69
10 0.32 0.68
11 0.35 0.65
12 0.32 0.68
Mean 0.34 0.66
SD 0.03 0.03
Table 3.11 The mean ratios of the thickness of the keratinised and cellular compartments 
against the total thickness for the four measured columns of the dorsal surface of tongue in the 
experimental group.
Animal RATIO KER:TOTAL RATIO CELL:TOTAL
16 0.34 0.66
17 0.31 0.69
18 0.31 0.69
23 0.34 0.66
24 0.31 0.69
26 0.28 0.72
Mean 0.32 0.69
SD 0.02 0.02
Table 3.12 The mean ratios of the thickness of the keratinised and cellular compartments 
against the total thickness for the four measured columns of the dorsal surface of tongue in the 
control group.
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Animal LSU LBM TKC TCC TOTAL
1 448.98 490.53 36.66 88.10 124.76
2 449.98 436.48 11.42 60.03 71.45
4 484.01 450.57 26.30 63.57 89.87
6 391.65 460.26 33.21 92.92 126.13
7 390.67 479.29 30.81 92.03 122.84
8 381.50 447.16 23.85 87.38 111.23
9 420.01 493.07 35.67 109.90 145.57
10 530.49 509.72 21.37 83.76 105.13
12 436.72 449.42 22.36 87.07 109.43
Mean 437.11 468.50 26.85 84.97 111.82
SD 48.52 25.34 8.12 15.15 21.78
Table 3.13 Quantitative histological analysis of epithelium from the ventral surface of tongue
of the experimental group. The values LSU and LBM represent the mean surface length and 
basement length respectively for the four measured columns of 228 pm width. The thickness 
measurements of die keratinised compartment (TKC), cellular compartment (TCC) and the 
combination of these (TOTAL) are in pm
Animal LSU LBM TKC TCC TOTAL
17 455.38 440.02 23.57 71.78 95.35
18 445.54 419.04 15.58 76.47 92.05
23 478.59 462.02 24.73 101.81 126.54
24 432.19 439.02 25.21 105.07 130.28
26 446.33 407.64 21.04 75.90 96.94
Mean 451.61 433.55 22.03 86.21 108.23
SD 17.21 21.00 3.95 15.88 18.55
Table 3.14 Quantitative histological analysis of epithelium from the ventral surface of tongue
of the experimental group. The values LSU and LBM represent the mean surface length and 
basement length respectively for the four measured columns of 228 pm width. The thickness 
measurements of the keratinised compartment (TKC), cellular compartment (TCC) and the 
combination of these (TOTAL) are in pm
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Animal RATIO OF KER: TOTAL RATIO CELL: TOTAL
1 0.29 0.71
2 0.19 0.67
4 0.29 0.71
6 0.26 0.75
7 0.25 0.75
8 0.21 0.79
9 0.25 0.75
10 0.20 0.80
12 0.20 0.80
Mean 0.24 0.75
SD 0.04 0.04
Table 3.15 The mean ratios of the thickness of the keratinised and cellular compartments
against the total thickness for the four measured columns of the ventral surface of tongue in 
the experimental group.
Animal RATIO OF KERiTOTAL RATIO CELL: TOTAL
17 0.25 0.75
18 0.17 0.83
23 0.20 0.80
24 0.19 0.81
26 0.22 0.78
Mean 0.21 0.79
SD 0.03 0.03
Table 3.16 The mean ratios of the thickness of the keratinised and cellular compartments
against the total thickness for the four measured columns of the ventral surface of tongue in 
the control group.
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CHAPTER 4
A DISCUSSION OF THE EXPERIMENTAL FINDINGS
4.1 STATUS OF ORAL EPITHELIUM
The studies reported in this thesis were designed to assess the effect on the oral epithelium in 
hamsters of a diet deficient in riboflavin. Riboflavin levels were monitored throughout using 
the erythrocyte glutathione reductase test. Several quantitative histomorphometrical 
techniques were used to determine whether any changes occurred in the oral epithelium. 
Several problems were encountered which did not allow final correlation of riboflavin 
deficiency with oral changes. However, in a pilot study, it was found that the length of the 
surface epithelium of the posterior lateral surface of tongue was significantly shorter in the 
experimental group implying that the surface was flatter. The length of the basement 
membrane in these sections was also significantly shorter implying that the rete ridges were 
less pronounced, and the cellular compartment was significantly thinner, implying atrophy of 
the epithelium in the experimental group (Carmichael and MacDonald, 1992). The initial 
findings seemed to suggest that riboflavin deficiency, like that of some other nutrients, could 
cause atrophy of the oral epithelium It is interesting to note that the area affected by atrophy 
was the posterolateral surface of the tongue. This finding was similar to that for other 
nutrients (Al-Damouk and MacDonald, 1987). It would appear that the dorsal and ventral 
surfaces of the tongue are possibly less susceptible to nutritional deficiencies. A number of 
problems had been encountered in the previous study which caused the validity of these 
findings to be questioned. These findings were not confirmed in the current study described 
in Chapter 3.
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As was stated in Chapter 1, no quantitative work has been carried out in an animal model on 
oral epithelial changes and riboflavin deficiency apart from a pilot study (Carmichael and 
MacDonald, 1972). Epithelial changes have been noted in mice (Wynder and Klein, 1965) 
and baboons (Foy et a l , 1972) but these were purely descriptive. In mice, initially epithelium 
developed atrophy, followed by hyperkeratosis and then hyperplasia. They proposed that the 
initial changes seen of atrophy were identical to those seen in starvation, but that later, 
hypertrophy of the epithelium, which developed during the fifth to eighth weeks could be 
specifically attributed to riboflavin deficiency. In baboons the oral epithelia showed irregular 
patchy hyperplasia, thinning and dysplasia. It may have been that the changes seen in the pilot 
study (Carmichael and MacDonald, 1972) were more consistent with general starvation, 
rather than due to specific effects of riboflavin deficiency. Certainly the results of the current 
study showed slightly significant differences (p<0.05) in the thickness of keratin of the dorsal 
surface of tongue, being greater in the experimental group and, in the length of the basement 
membrane of the ventral surface of tongue, being longer in the experimental group. No 
significant differences were noted on the posterolateral surface of tongue. These changes 
were similar to those noted subjectively by Wynder and Klein (1965) and Foy et al. (1972). 
A number of studies have examined the influence of riboflavin deficiency on carcinogenesis 
and as has been already stated, the apparent effects are contradictory. In the current study, 
marginal riboflavin deficiency was produced and this had the effect of producing a thicker 
keratin layer and longer basement membrane. These may be protective features against 
topical carcinogens and therefore the apparent protective effect of riboflavin deficiency may 
only occur with chronic, marginal deficiency. In contrast, the apparent potentiating effect of 
riboflavin deficiency may occur in severe deficiency states, when epithelial atrophy may be 
produced. If the latter is true, it could be due to the effect of riboflavin deficiency on the
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metabolism of other nutrients. This could be an area of future research in the hamster cheek 
pouch model or in application of carcinogens to the lingual epithelium In particular, 
comparing groups with optimum riboflavin levels, marginally and severely deficient. Perhaps 
utilising a riboflavin antagonist to ensure severe deficiency.
4.2 RIBOFLAVIN TESTING
Chapter 2 described the initial testing of hamster blood for riboflavin levels. A variety of 
methods have been used in other in vivo studies. The microbiological and fluorometric 
methods have been used in early studies, but usually at the end of the experiment to assess 
riboflavin levels in liver tissue (Salley and Weatherred, 1964). This would have been 
unsuitable as a method of monitoring in the current study as it was necessary for all the 
animals to survive to the end of the experimental period. In previous studies, riboflavin levels 
were not monitored during the experimental period and weight loss alone was used as a 
marker of developing deficiency (Wynder and Klein, 1965: Foy et al, 1972). In one of the 
few papers describing riboflavin deficiency in the hamster, the erythrocyte glutathione 
reductase test was utilised (Kim and Roe, 1985). They did not mention encountering any 
particular problems with riboflavin testing in the hamster model using this method. The 
activation coefficients in all their groups after eight weeks on diets containing a varying 
amount of alcohol and riboflavin were higher than found in all our animals at weeks five and 
eleven. They did report the activation coefficients as means of groups, rather than as 
individual animals. It would appear that at least one of their animals had an activation 
coefficient of over 1.7 which was much higher than any achieved by our animals. This animal 
was in a group also supplied with alcohol which appeared to induce more severe deficiency.
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However, even in their control group, with optimum levels of riboflavin and no alcohol, the 
mean activation coefficient was higher at 1.32 than the mean for the group fed the deficient 
diet in our experiment which was 1.2. Kim and Roe (1985) did not mention optimising the 
technique for hamster blood and as was found in Chapter 2, the activity of FAD in hamsters 
is much less than in humans which may lead to less precision in calculations. Kim and Roe 
(1985) also found that there were initial fluctuations in riboflavin levels, with initial increase 
in AC up to week two followed by a drop in weeks 4-6 and an increase on week 8. They 
attributed this effect to refection. Coprophagy was not prevented in the current experiment 
and so this may have had some effect on the results described.
The activation coefficients found in studies on the rat are far higher than those seen in the 
hamster, or for that matter in humans. Mean values for a group fed a riboflavin deficient diet 
have been quoted as 2.66 (Adelekan and Thumham, 1986) and 2.54 (Gomez et a l , 1988). It 
is interesting to note that in these papers, no reference is made to a different threshold for 
deficiency in the rat, or that the levels were particularly high.
4.3 PROBLEMS WITH DIET
Due to the problems encountered regarding animal health, and the apparent resistance of the 
animals to becoming biochemically deficient despite considerable time on the diet, the diets 
supplied were examined for bacterial contamination and at the same time the riboflavin levels 
were checked. Two separate analyses were carried out, one by the company supplying the 
diet and by an independent firm. They confirmed that there was no bacterial contamination of 
the diet. The riboflavin levels measured, differed from those requested. The deficient diet had
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higher levels than expected and the levels in the control diet were lower than expected. When 
the supplier was contacted they stated that these would be the levels expected if lOmg/kg of 
riboflavin was added to the basal diet. The diets are based on purified raw materials as 
opposed to natural cereal based ones. They utilise materials such as casein, cellulose powder 
and cornstarch as these materials have naturally low levels of many components including 
minerals and vitamins. The use of synthetic diets allows good control over nutritional levels. 
The supplier felt that any discrepancies were due to the method of analysis. They used a 
microbiological assay which often gives results lower than expected. The variation is what 
would be expected between laboratories or even repeated assay by the same laboratory. They 
also quoted the recommended riboflavin levels for hamsters as being 10-15mg/kg of diet. In 
view of the smaller difference in dietary riboflavin levels between the two groups, it was not 
surprising that no significant changes were found in any of the epithelial parameters 
measured. There were also differences in the measured levels of dietary riboflavin from the 
two testers. The independent tester measured higher levels than the supplier. This may reflect 
different methods of testing, or that the diet varied considerably in riboflavin content 
throughout batches. If the riboflavin content varied to this degree, it may be that other 
nutritional factors were altered. It may have been that if the diet was old or had been exposed 
to sunlight this had caused a reduction in riboflavin content. It could be argued that as severe 
deficiency of a single nutrient is unlikely in the general population, rendering the animals 
chronically marginally deficient, would be more appropriate to the real life situation. Only 
one control animal was rendered marginally deficient by week one, whereas four became 
marginally deficient in the experimental group. It would be interesting to carry out a similar 
experiment with three different levels of riboflavin in the diet, <lmg/kg, 5mg/kg and
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>15mg/kg in order to compare the epithelium in animals severely deficient, marginally 
deficient and normal
4.4 HEALTH OF ANIMALS
The health of the animals proved troublesome and the experiment was terminated at 11 
weeks. Several animals died and three further animals were recruited into the control group. 
A number of animals became riboflavin deficient in the experimental group, but so too did 
three of the control animals.
Hamsters are not resilient laboratory animals. Once an epidemic of “wet tail” starts in a 
hamster colony, it can be difficult to controL Tetracycline can be used to treat this 
gastrointestinal infection, but were not in this series as the use of antibiotics can interfere with 
normal riboflavin levels if bacteria in the gastrointestinal tract compete for riboflavin stores. 
This can have the effect of raising the animals riboflavin levels if the bacteria are killed or it 
can have the reverse effect if the antibiotic spares some gut bacteria which then are able to 
multiply and they have a greater requirement for riboflavin than the normal flora. As the 
animals were suffering from diarrhoea, transit times would have been altered thus allowing 
less time for absorption from the gastrointestinal tract. This may also have induced multiple 
vitamin deficiencies. Kim and Roe (1985) reported in their experiment that six of 36 hamsters 
were lost. No reason was given for this and we have no way of ascertaining whether these 
were during bleeding, due to riboflavin deficiency or due to infection.
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4.5 CONCLUSION
The studies reported in this thesis confirm that hamsters do have a dietary requirement for 
riboflavin and that marginal deficiency can be induced by a riboflavin deficient diet. The aim 
of this group of experiments was to ascertain whether isolated riboflavin deficiency could 
bring about epithelial changes, particularly atrophy, which could make the oral epithelium 
susceptible to carcinogens.
Riboflavin deficiency is linked to deficiencies of other nutrients such as folate and it is 
therefore difficult to identify if any one factor is the cause of atrophy. It is also unusual in 
nature to have an isolated deficiency of one B group vitamin.
The number of animals dying during the experimental period was abnormally high. No 
specific bacterial pathogen was ever identified from the dietary source. It may have been that 
suboptimal nutrition rendered the animals more susceptible to infection.
Another major problem encountered was the unexpected levels of riboflavin found in the 
diet. The diets were ordered from a reputable supplier and were to have contained specified 
levels of riboflavin. It was an error not to have confirmed the exact levels by analysis before 
the experiment. However, the supplier was satisfied that the levels of riboflavin in both the 
experimental and control diets were as expected.
In view of the findings reported in this thesis, further work is indicated. If it was to be carried 
out in the hamster model, the diet supplied should be examined carefully prior to use. It may 
however be possible to carry out a similar set of experiments using an organ culture deprived
92
of riboflavin, perhaps by using a riboflavin antagonist such as galactoflavin. It would also be 
of interest to investigate whether riboflavin deficiency alters the rate or number of tumours 
induced by a chemical carcinogen.
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